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Abstract
Advances in imaging technology have led to a variety of available clinical and investigational
systems. In this collection of studies, we tested the relevance of morphological image feature
quantification on several imaging systems and epithelial tissues. Quantification carries the
benefit of creating numerical baselines and thresholds of healthy and abnormal tissues, to
potentially aid clinicians in determining a diagnosis, as well as providing researchers with
standardized, unbiased results for future dissemination and comparison.
Morphological image features in proflavine stained oral cells were compared qualitatively to
traditional Giemsa stained cells, and then we quantified the nuclear to cytoplasm ratio. We
determined that quantification of proflavine stained cells matched our hypothesis, as the nuclei in
oral carcinoma cells were significantly larger than healthy oral cells.
Proflavine has been used in conjunction with translational fluorescence microendoscopy of the
gastrointestinal tract, and we demonstrated the ability of our custom algorithm to accurately (up
to 85% sensitivity) extract colorectal crypt area and circularity data, which could minimize the
burden of training on clinicians. In addition, we proposed fluorescein as an alternative
fluorescent dye, providing comparable crypt area and circularity information.
In order to investigate the morphological changes of crypts via the supporting collagen
structures, we adapted our quantification algorithm to analyze crypt area, circularity, and an
additional shape parameter in second harmonic generation images of label-free freshly resected
murine epithelium. Murine models of colorectal cancer (CRC) were imaged at early and late
stages of tumor progression, and we noted significant differences between the Control groups
and the late cancer stages, with some differences between early and late stages of CRC
progression.
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Chapter I: Introduction
1. Background
1.1 Clinical imaging and diagnosis of oral and colonic epithelial cancer
Cavities in the gastrointestinal tract, from mouth to rectum, are lined in a layer of
epithelial cells [1]. The epithelium, the layer of epithelial cells, forms a barrier between outside
substances and the rest of the body’s organs and bloodstream, as well as often facilitating the
transfer of necessary solutes and solvents from ingested substances [1]. The mucosa consists of
the epithelium and an underlying layer of nerves, vessels, and a thin layer of smooth muscle [1].
In the mouth, while there are various types of oral mucosa including masticatory mucosa
(tongue, palate, gums), lining mucosa (cheeks, mouth floor, inside of lips), and specialized
mucosa (taste buds), the epithelial layer largely consists of squamous epithelial cells [2]. In the
gut, the mucosal surfaces vary and can include either squamous epithelium (esophagus) or
columnar epithelium (stomach, intestines) [2]. Figure 1 compares the different types of
epithelium, including squamous epithelium, which consists of flat cells, and columnar
epithelium, which consists of tall narrow cells [2].

Figure 1. Types of epithelium. Image sourced from seer.cancer.gov webpage [3].
Diagnosis of epithelial dysplasia (abnormal cellular behavior) and cancer is achieved by
histopathological analysis of a biopsy or resected tissue. White-light wide-field microscopes are
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a clinical standard for imaging and pathological diagnosis of sectioned tissue (such as from
biopsies) or fluid samples (such as blood or fecal smears) [4]. Contrast agents are of vital
importance in most pathology applications, as the tissues being imaged typically do not exhibit
inherent differences in color. Tissue sections are commonly stained with hematoxylin and eosin
(H&E) in order to differentiate the nuclei (dark purple) from the surrounding tissue (pink) [4].
Pathologists are trained to detect abnormalities in H&E stained cells by analyzing nuclei (purple)
shape and distribution, and cellular (pink) morphology and organization. Examples of oral (Fig.
2) and colonic (Fig. 3b) H&E stained epithelium are shown below [5, 6].

Figure 2. H&E images of healthy oral mucosa and oral squamous cell carcinoma. Images
modified; left acquired at x100 magnification, right acquired at x400 magnification [5, 7].
Healthy oral epithelium (Fig. 2a) has a stratified squamous arrangement of cells, with
layers of squamous cells (non-proliferating flat cells) laid over basal cells (proliferating cells).
Healthy colonic epithelium (Fig. 3a-c) has a columnar arrangement, with cells forming tubular
structures called crypts, which have a collagen sheath that provides structure and different types
of epithelial cells lining the sheath [8]. En face views of healthy crypts display roughly circular
crypt openings of homogenous size (Fig. 3c). Basal cells lie at the base of crypts, with
differentiated non-proliferating epithelial cells migrating toward the top of the crypt, and are
eventually exfoliated into the colonic cavity.
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Precursor lesions for oral cancer can take an average of two and a half years to progress
to cancer [9]. Patients who regularly smoke and/or drink alcohol are at increased risk since
tobacco and alcohol are the two major etiologic agents in oral cancer [9]. Histological findings
for white (leukoplakia) or red (erythroplakia) oral lesions can vary, and therefore these lesions
are simply flagged for further testing, not used as a final diagnosis [9]. There are various
morphological changes that are used in diagnosing oral squamous cell carcinoma (Fig. 2b),
including increased nuclear to cytoplasmic ratio, increased number or abnormal mitotic figures,
cellular and nuclear pleomorphism (heterogeneity of size/shape), and irregular epithelial
stratification [9].
Adenomatous polyps, small benign growths, can sometimes progress into colorectal
cancer (CRC) [10]. While most CRC originate from these polyps, they can take years to develop
into CRC, with approximately 74% of cases documented in patients over the age of 60 [10].
Early stages of CRC, before the development of grossly visible polyps, will typically include
regions of abnormal cellular organization, for example, aberrant crypt foci (ACF) which are
enlarged or non-tubular (branching) crypts, and/or multiple layers of cells lining a crypt (Fig. 3d)
[11, 12].

Figure 3. Examples of colon crypt morphology. (a) Representation of crypts in the epithelium;
modified figure [13]. (b)Transverse section of colonic murine epithelium; scale bar is 500 µm.
(c) En face view of epithelial layer; scale bar is 100 µm. (c) En face view of an ACF: center
crypt is larger and has a higher number of elongated nuclei compressed around the crypt; scale
bar is approximately 100 µm. Modified figure [14].
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Cytology, which specifically studies cellular image features, is a branch of pathology that
has been clinically applied to diagnosis of cells in cervical, anal, and urine smears, and aspirated
and exfoliated cells [15-19]. Oral cell cytology, specifically, uses colorimetric stains such as
H&E and Papanicolaou for white-light wide-field microscope image acquisition [19]. Another
clinical application of white-light wide-field microscopes are endoscopic systems, e.g.
colonoscopes. Endoscopic imaging systems usually consist flexible probes that can be inserted
into the body to inspect organs, such as the esophagus, stomach, and colon. Colonoscopy
systems, used to screen for abnormalities such as discoloration or polyps, consist of a long
flexible probe that transmits light from a white-light source to illuminate the colorectal tract as
well as transmitting an image back into the external system for acquisition with a wide-field
camera. The images are displayed to the clinician in real-time and can be used to guide
acquisition of biopsies as needed. While ubiquitous, white-light wide-field imaging systems are
not the only imaging modalities used in clinical settings; various additional optical imaging
modalities are described below.
1.2 Optical imaging modalities
Microscopes – and microscopy – fall under the category of optical imaging, which
according to the NIH is an imaging technique that uses wavelengths in the range of visible light
[20]. Other common clinical imaging modalities include MRI (magnetic resonance imaging), Xray, and CT (computed tomography) systems, but these are not optical imaging modalities.
Contrast in MRI is created by a magnetic field, and relies on the differences in radio frequency
signals to distinguish between soft tissues (Fig. 2) [21]. Contrast in the X-rays are due to
differences in tissue density; dark regions in the black and white image represent low-density
regions where the x-ray emissions passed through, and brighter regions represent high-density
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regions where calcification (teeth, bone) block the signals from reaching the sensors [22]. CT
imaging also uses x-ray, but the sensors are set at many different angles around the patient and
the signals are then computationally restructured into multiple images and/or a 3-dimensional
model [23].
Advantages of using optical imaging include reduction of patient exposure to radiation,
image acquisition of specific or targeted molecules, as well as the option to utilize various
colors/wavelengths to probe various properties simultaneously [24]. For example, common
dental x-ray imaging systems produce sufficient x-ray radiation to be regulated and considered
cause for concern, with CT producing higher doses of radiation [25-27]. While occasional use is
not considered to be of high risk, it poses an increased risk to patients undergoing continuous
screening/treatment [25, 27]. While optical imaging could cause local damage within tissue if the
optical power is high and/or continuous, low level laser therapy has been used clinically and
optical power dosage guidelines have been published to prevent adverse effects [28]. High
optical power even has been used in combination with experimental drug delivery carriers, which
are activated by targeted pulses of high optical power in order to obtain an accurate and
controlled increase temperature in a region of interest [29, 30]. Another advantage of optical
imaging is the ability to stain or immunolabel different molecules with different colorimetric
markers and simultaneously or sequentially acquire images of various molecules in the same
sample [31, 32]. An example of this are composite fluorescent images of cells that display blue
nuclei and red actin fibers [33].
MRI does not carry the risk of radiation, but is also is limited to probing for differences in
density in soft tissues, whereas optical imaging systems, such as H&E staining of tissue sections
or multiphoton microscopy, can acquire functional information such as nuclear and cellular
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morphology [34, 35]. The greatest disadvantage of optical imaging is the scale, or field of view
and depth, that can be acquired using the visible light spectrum. Wide-field microscopes require
thin sections of tissue, typically in the range of 5μm-10μm, or equally thin smears of fluid
samples. Microendoscopes are limited to investigating the topmost layers that the imaging probe
comes into contact with. Multiphoton imaging is the most capable of imaging deeper into tissue,
up to several hundred microns into tissue depending on the type of tissue [36].
Fluorescence and fluorescence microscopy
Due to the central role of cellular morphology in clinical diagnosis, optical imaging
alternatives to tissue removal and subsequent H&E staining have been widely investigated.
Sources of contrast in imaging of epithelium range from colorimetric stains, to fluorescence and
autofluorescence. Colorimetric stains, such as the previously described H&E (Fig. 2), Giemsa,
and others, display visibly distinguishable colors when viewed with a white light source [4, 37].
Fluorescence, in broad terms, is the result of electrons in susceptible molecules absorbing energy
when targeted with light (excitation), becoming energized and entering a higher energy state, and
releasing a reduced amount of the energy (emission) when returning to their original state (Fig.
4a). As can be seen in Figure 4b, the blue extinction curve displays the efficiency of various
excitation wavelengths (intensity of the fluorescence when excited at a given wavelength) and
the orange emission curve represents the intensity of different emitted wavelengths when excited
with 400nm light. Fluorescent contrast agents can be applied to add contrast to cellular
structures, or highly sensitive imaging systems can be used to acquire fluorescent signals from
endogenous fluorophores present in cells [34, 35].
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Figure 4. Example of fluorescent excitation and emission. (a) Jablonski diagram showing an
electron being excited by a photon into a higher energy state, then relaxing and releasing
fluorescent light. (b) Extinction/emission curves for proflavine; adapted from PhotochemCAD 2
data [38].
Cells have some measure of endogenous fluorescent molecules, but these fluorescent
emissions are too dim to image using wide-field microscopy. Confocal imaging systems are
sensitive enough to capture this endogenous fluorescence, though sometimes confocal systems
will still be used in conjunction with fluorescent contrast agents. Confocal laser systems rely on a
small pinhole to eliminate out-of-focus light, and this pinpoint of light is scanned across the field
of view, acquiring an image pixel by pixel using highly sensitive detectors (photomultiplier
tubes). Fluorescence imaging, including confocal microscopy systems, have a light source of
higher-energy/shorter-wavelength which is used to stimulate the emission of lowerenergy/longer-wavelength signals.
Multiphoton fluorescence microscopy: two photon excitation
In contrast to confocal systems, multiphoton microscopy takes advantage of a
phenomenon in which two (or more) photons of light excite a molecule at virtually the same time
and place (a cross section of 10−50 cm4 s) and the electron absorbs the energy of both and
therefore releases light of longer wavelength than the combined energy, but shorter than the
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original light source (Fig. 5) [39]. Practically, this means that a pulsed high-frequency red light
can be used to excite molecules that typically require blue light excitation. Due to the reduced
Rayleigh scattering of longer wavelengths, multiphoton microscopy allows for imaging deeper
into tissue sample, as well as virtually eliminating any shorter wavelength excitation outside of
the focal plane [39]. This reduction of out-of-focus fluorescence means that multiphoton imaging
is ideal for label-free imaging of endogenous fluorophores present in tissue.

Figure 5. Example of two-photon fluorescence. Jablonski diagram showing an electron being
excited by a combination of two photons into a higher energy state, then relaxing and releasing
fluorescent light.
Second harmonic generation imaging
Multiphoton imaging systems have also been used for acquiring second harmonic
generation (SHG) signals. SHG is a nonlinear optical process in which two equal-energy photons
interact with a nonlinear medium and produce, without absorption nor energy loss, a single
photon of half the original wavelength of the excitation [40, 41]. A linear optical process is when
two waves (sound, light, etc.) combine constructively, where components combine into a single
wave of greater amplitude, or destructively, where positive and negative components cancel out
into a lesser amplitude or completely zero [40, 41]. A nonlinear optical process is when two light
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waves do not combine to produce a greater amplitude, but combine to produce a wavelength of
equal amplitude but higher frequency [40, 41]. SHG requires a nonlinear medium to mediate this
production of higher-frequency photons. The refractive index of a nonlinear medium changes
with light intensity, thereby changing speed/frequency [40, 41]. This process usually occurs at
high frequencies, such as in pulsed photons emitted by a femtosecond laser (commonly used in
multiphoton microscopy), and depends on the degree of the polarization of a nonlinear medium
[40, 41]. This nonlinearity, including the polarization of the medium, leads to the generation of a
wave at twice the original frequency. This means that certain nonlinear endogenous molecules,
most relevant for this manuscript being collagen, can be imaged using multiphoton microscopy.
The following sections describe different optical imaging modalities, contrast agents,
and techniques that were applied to investigation of morphological image features in oral and
colorectal epithelial cancer cells.
2. Proflavine as a contrast agent for oral cell cytology
2.1 Oral squamous cell carcinoma
Oral and pharyngeal cancer is the sixth most common cancer worldwide, with two thirds
of cases arising in developing countries [42]. In countries with the highest incidence rates, for
example Sri Lanka and India, oral cancer is the most common cancer in men, contributing up to
25% of all new cancer cases [42]. Oral squamous cell carcinoma (OSCC), one subtype of oral
cancer, is the most common malignant tumor of the head and neck [43]. For many populations,
including Asia, tongue and buccal (cheek) mucosa are the most common incident sites of oral
cancer [44]. Oral epithelial dysplasia (OED) is the histological marker of premalignancy, and
carries an increased risk for developing OSCC [45]. Typical histological markers to diagnose
OED include, but are not limited to, loss of cellular organization, enlargement of nuclei, basilar
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hyperplasia, mitosis above the basal cell layer, and skip areas of dysplasia [46]. In 16% of cases,
OSCC developed within 6.5 years after an OED diagnosis [46].
OSCC is diagnosed either during a routine inspection of the oral cavity by a dentist or
physician, or due to a patient presenting discomfort or suspicion [47]. In a low-resource location
in Bangladesh, 85%-95% of cases in a clinical study had a history of irregular (less than yearly)
dental visits, reducing the likelihood of early detection of OSCC [48]. In order to address this
lack of medical surveillance in low-resource settings, there have been various attempts made to
conduct screening initiatives, such as sending health workers and volunteers to rural areas in
order to conduct routine inspections, specifically looking for white or pink lesions, or visible
growths [49]. A study by Wesley et.al. compared results from two cancer detection camps versus
youth volunteers sent to visit households in the area and reported more favorable results from the
cancer detection camps [50]. Studies reported compliance (accepted invitation for follow-up at a
clinic) percentages for industrialized countries as high as 100%, while most studies conducted in
the Indian sub-continent hovered around 50% [50]. While screening initiatives have provided
many with the opportunity for earlier detection of OSCC, there is still a need for point-of-care
diagnosis that can more easily reach these high-risk populations.
In order to increase early diagnosis, and therefore increase survival rates, multiple
screening tools for oral cancer have been developed to diagnose lesions early, expedite
treatment, and do not necessitate high levels of training. Alternative oral screening procedures
are designed to collect exfoliated cells, such as oral rinses and oral brushes to more stringently
exfoliate cells of a suspicious region, for subsequent histopathological examination [51]. Kujan
et. al. discussed the difficulty of using cervical cytobrushes for their oral study, due to “their size
and shape”, since at the time there was no commercially available cytobrush [52]. Currently, the
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most commercially accepted clinical on-the-market oral screening tool is the OralCDx brush,
which is marketed for scrubbing of suspicious regions, then sending the brush and exfoliated
cells to their laboratory for diagnosis [53, 54]. Investigational cytological studies included
similar procedures, and stained the exfoliated cells with a variety of contrast agents [51].
2.2 Cytological contrast agents
Once oral cells have been exfoliated, one of many contrast agents are applied in order to
highlight the morphological image features used to determine a diagnosis [55]. The most
common cytological contrast agents in oral cytology are Feulgen, acridine orange, propidium
iodine, Giemsa, May-Grünwald-Giemsa, and ethidium bromide [55]. These contrast agents fall
into either the category of a colorimetric contrast agent that requires white light and a color
camera, or a fluorescent contrast agent that requires a small range of excitation wavelengths (e.g.
an LED or laser) and a filter set. While colorimetric stains (e.g. Feulgen, Giemsa) are current
contrast agents used for oral cytology, fluorescent dyes (e.g. acridine orange, propidium iodine,
ethidium bromide), depending on the stain and the application, have benefits that include higher
signal to background during imaging, rapid staining, little or no need for fixation, low cost, and
minimal need for lab tools. Qualitatively, fluorescent imaging is comparable to colorimetric
methods when considering morphological features, specifically nuclei size and distribution.
Propidium iodine and ethidium bromide are commonly used in live/dead cell assays, and
therefore the majority of the studies where they were used as contrast agents, they were used to
stain the nuclei of dead or fixed cells, or were shown incapable of staining any of the nuclei in
the live cells of the study [55]. An alternative in the acridine derivative family is acridine orange,
which is used in many applications requiring different colorimetric features to differentiate cells
with varying cellular content, such as the acidic vesicles [56, 57]. However, the fluorescence
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emissions of acridine orange are dependent on concentration, pH and incubation time and it
requires strict control. For applications where colorimetric-based differentiation between
multiple cell types is not necessary and morphological features would suffice, proflavine would
be a more suitable contrast agent for oral cytology.
Proflavine is a fluorescent DNA-intercalating dye, of the aminoacridine derivative
family, with amphipathic properties that allow for rapid absorption into the cell cytoplasm and
nuclei [58]. Proflavine has been used clinically since 1917 [59], but its use as a cytological tool
is not widespread despite its potential advantages, though there has been renewed interest in its
use for point-of-care diagnostic applications in low-resource settings due to its physical and
chemical stability in solution [60]. Proflavine is very stable in solution, up to 12 months if
refrigerated [60]. Proflavine is useful in applications that require minimal preparation and
staining steps, as well as high signal to background, as a fluorescent dye that can rapidly stain
live cells, unlike the previously described contrast agents, and is not pH dependent, unlike other
dyes in the aminoacridine family.
2.3 Objective
Rapid identification of oral cells with large nuclei to cytoplasm ratios using low-cost
fluorescence imaging systems could serve in further development of point-of-care OSCC
screening tools. Proflavine, a DNA-intercalating vital dye, could serve as an alternative contrast
agent for oral cytology screening systems in regions where clinical pathology services are not
readily available.
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3. Image feature quantification and alternative contrast agent for a translational
microendoscopy system
3.1 Colorectal cancer
Colorectal cancer (CRC) causes approximately 50,000 deaths per year in the United
States, with 14.5 deaths per 100,000 men and women [61]. When diagnosed early, the 5 year
survival rate can be over 90%, but unfortunately over 20% of cases are diagnosed at a late stage
when the survival rate drops below 14% [61]. There are various types of CRC, including
familial, familial adenomatous polyposis (FAP), hereditary nonpolyposis (HNPCC), ulcerative
colitis/Crohn’s disease related, rare syndromes such as Lynch and hamartomatous polyposis
syndromes, and – the most prevalent – spontaneous adenocarcinoma [62, 63]. Spontaneous
adenocarcinomas, accounting for 65-85% of CRC cases, commonly arise from adenomatous
polyps, some of which may progress into invasive adenocarcinomas over time (Fig. 6) [62,
64]. This progression is thought often take years (up to a decade) and be dependent on the size
and histology of the polyp [65]. Routine screening can lead to early detection and removal of
polyps, which can reduce the number of CRC deaths.

Figure 6. Stages of colorectal cancer. Image sourced from www.shsg.com.au.
13

Routine screening of CRC depends on traditional colonoscopy, which utilizes long
flexible probes attached to a white light illumination source and a wide-field color camera, which
is then inserted into the colon to screen for any grossly visible polyps [6]. The physician inspects
for any visible growths or suspicious lesions, such as discolored or inflamed epithelium [2].
Small polyps can be removed immediately during the colonoscopy [66], and are sent to the
pathologist to determine if it was a benign growth or if it requires additional removal of
surrounding tissue. Any suspicious lesions are biopsied, the recommended number being fourquadrant biopsies every 10 cm [67]. Due to the increased number of people undergoing routine
screening, yearly CRC cases for those over 50 years of age have decreased 32% between 2000
and 2014 [68]. Despite this decrease, CRC remains the second leading cause of death in the US,
and third leading cause worldwide [61].
3.2 Recurrence and endoscopic imaging of colorectal cancer
Once a polyp has progressed into CRC, the curative standard for CRC is excision of the
tumor, often followed by surveillance for recurrence [69, 70]. Chemotherapy and radiotherapy
are common treatments designed to reduce the size of the tumor before resection, and/or prevent
metastasis of cancer cells from the tumor [69, 70]. Despite therapeutic treatment, recurrence is a
common outcome after resection of the primary tumor. In one randomized study, cancer recurred
in 44% of patients, leading to further surgery [70]. The majority of these recurrence-related
surgeries were performed within the first two years following the initial resection [70].
There are a number of tools that have been developed to determine recurrence during
surveillance of patients, including detection of a range of salivary protein markers [71]. An
alternative technique is the investigation of endoscopic imaging modalities, since operating
rooms and clinicians are already equipped for these imaging systems due to the widespread use
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of endoscopic probes, such as during colonoscopies or robotic surgery [72]. Examples of
imaging modalities that have been developed and tested in colorectal epithelium include
chromoendoscopy, indigo carmine staining in conjunction with traditional colonoscopy, and
microendoscopy. There are a variety of sources of contrast used in endoscopic imaging of
colorectal epithelium, such as colorimetric stains in chromoendoscopy, hemoglobin absorption in
narrow-band imaging, fluorescence in microendoscopic imaging, and autofluorescence in
confocal and multiphoton imaging systems. Chromoendoscopy typically uses a colorimetric
contrast agent, such as indigo carmine, to enhance dysplastic regions under traditional white light
colonoscopy [73]. Narrow band imaging has been described as label-free chromoendoscopy, as
optical filters only allow imaging of a small range of wavelengths, which enhance blood vessels
and contrast in capillary patterns without the need for indigo carmine or another contrast agent
[74, 75]. Laser endomicroscopy allows for imaging of cellular and subcellular structures,
providing more detailed imaging of features that relate more closely to histopathological features
[76].
One robust imaging modality, fluorescence microendoscopy, combines the untargeted
staining method of chromoendoscopy with the microstructural detail of microendoscopy.
Microendocopy is an imaging system that has been investigated due to its robust and relatively
inexpensive build, and its ability to provide a detailed look at cellular structures that are not
visible during routine wide-field endoscopy [77-79]. Microendoscopy imaging techniques that
have been developed to provide complementary information for the clinician during a
colonoscopy include autofluorescence endoscopy with image processing, narrow band
reflectance imaging, and combined multimodal methods [66, 80, 81]. Microendoscopic imaging
using proflavine (the previously described DNA-intercalating fluorescent contrast agent) has
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been investigated in clinical settings, in conjunction with manual quantification of image features
[79, 82-86]. Limitations of fluorescence microendoscopic imaging include limited imaging
depth and small field of view. Advantages of microendoscopic imaging using proflavine include
rapid staining times, no need for rinsing, high signal to background ratios, and high-resolution of
cellular structures. Qualitative analysis of morphological structures (such as glandular shape,
epithelial thickness, and nuclear organization) in images acquired with fluorescence
microendoscopy by trained observers has been shown to be highly sensitive and specific (over
90% for both) [86]. Since the use of proflavine has been limited to investigative studies, we have
also explored the use of fluorescein as an alternative contrast agent to proflavine, due to its FDAapproved intravenous use for alternate applications [87].
3.3 Manual and automated quantification of morphological image features
An additional tool that we investigated was the automated quantification of image
features, specifically the size and shape of crypt structures. Image feature quantification could be
defined as numerical measurement of an object or multiple objects in an image, as opposed to
coming to a conclusion or diagnosis based on observation alone. Counting polyps in the
colorectal tract during routine colonoscopies is a basic example of image quantification; a
diagnosis of familial adenomatous polyposis “is made when at least 100 colonic adenomas are
identified” [88]. This example highlights how thresholds, such as the numerical value of 100
polyps, can be determined based on clinical studies, and can be used as a suggested value for
diagnosis.
Manual quantification exists in varying degrees in cancer research and clinical workflow,
such as the aforementioned examples of polyp counting during a colonoscopy. Manual
quantification retains the advantages of observer-based analysis and image quantification by
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using trained clinicians to accurately select important image features (such as distinguishing
polyps from surrounding tissue), and adds the advantage of numerical results that can be
replicated and used to create thresholds and ranges of normalcy (such as selecting 100 polyps as
a numerical threshold). When comparing diagnoses of dysplasia – presence of abnormal cellular
morphology and/or organization that are a precursor to cancer – in colorectal microendoscopy
images by experienced clinicians, inter-observer variability among trained observers was 96%
[89]. While manual quantification retains the high accuracy feature analysis when using trained
clinicians, it also retains the disadvantage of requiring an experienced observer, as well as the
burden of spending increasingly longer periods of time spent analyzing the data especially as
modern imaging systems increase their capability of acquiring large image data sets.
Automated quantification uses trained algorithms to select, segment, and quantify image
features independent of the user. Automation is targeted at the reduction of the burden of time on
trained clinicians, as well as reducing user-bias and error of minimally trained clinicians or
researchers. Minimally trained users are more likely to include false positives or a false negative.
An example of a false positive would be determining that a certain cell is dysplastic when it is
healthy, while a false negative would be determining that a certain cell is healthy when it is
dysplastic [89, 90]. A few of the studies that utilize automated quantification include automated
image segmentation of cells to measure cellular metabolic rates [91], segmentation of renal
sections to calculate fibrosis [92], and 3-dimensional fiber orientation [93].
3.4 Objective
Automated quantitative analysis of morphological features in microendoscopic images
can provide an objective method of distinguishing between normal and neoplastic regions.
Complementary microendoscopic-level information can be included into traditional colonoscopy
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workflow, as demonstrated by various studies, and can increase detection of neoplastic lesions at
an early stage, with automated quantification minimizing user effort and bias. The use of
fluorescein, currently approved for intravenous use in certain clinical applications, in conjunction
with these microendoscopic systems could provide investigators an alternative contrast agent
with similar quantitative results for translation into in vivo study.
4. Second harmonic generation imaging of murine epithelium for crypt morphology image
feature analysis of spontaneous and colitis-associated colorectal tumors
4.1 Ulcerative colitis and colorectal cancer
Ulcerative colitis (UC) and Crohn’s disease are the two major forms of inflammatory
bowel disease (IBD), which is characterized by chronic inflammation of the gastrointestinal tract
[94]. UC is characterized by severe inflammation and extensive ulcers on the epithelial surface
of the gastrointestinal tract [95]. Crohn’s disease is characterized by lesions over Peyer’s patches
(lymphatic tissue found in the ileum region), and the inflammation is non-continuous in location
as well as spanning the entire depth of the intestinal wall [95-97]. There has been progress in
discovering possible genes that contribute to disease susceptibility, as well as a rise in IBD
patients in previously low-risk countries showing the likely correlation between environmental
factors and IBD, but despite these studies there is still much of the pathogenesis of IBD that is
yet to be understood [95].
While there is no individual endoscopic or histological result that is specific for UC or
Crohn’s disease, an important distinction is the distribution pattern of the inflammation. UC is
diagnosed when examination shows continuous inflammation of the colon beginning at the
rectum, whereas a diagnosis of Crohn’s disease is determined when there are lesions over
Peyer’s patches [95-97]. Patients with UC have long been considered at increased risk for
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colorectal cancer (CRC), though there are less conclusive studies on the risk of CRC in patients
with Crohn’s disease [98-102]. While both types of IBD are associated with inflammation, in UC
pro-inflammatory cytokines are believed to directly influence cancer progression [103], and
patients are commonly provided with anti-inflammatory therapy, such as 5-aminosalicylic acid
[62]. Unfortunately, even this therapy is only able to achieve remission in 1 of 6 patients [104].
4.2 Spontaneous and colitis-associated tumor development in ulcerative colitis patients
Due to the high risk of UC patients developing CRC over time, if malignant lesions are
discovered the standard of care is curative colectomy (complete removal of the colon) [62, 105].
Within 10 years of diagnosis, approximately 29% of UC patients develop CRC compared to
2.9% of patients with Crohn’s disease [99, 101, 106, 107]. UC patients are more often considered
candidates for curative colectomy, since they have continuous inflammation of the colon [108].
The gold standard for detection and diagnosis of malignant lesions and/or tumors in IBD patients
is routine surveillance colonoscopy and subsequent endoscopic biopsy. Surveillance procedures
are designed to detect early dysplasia and neoplasia (pre-cancerous abnormalities), in order to
prevent CRC progression. Two types of lesions detected during colonoscopy, associated with
intraepithelial neoplasia, are dysplasia-associated lesion/masses (DALM) and adenoma-like
masses (ALM) [74, 105]. A DALM is classified when a lesion is flat or raised but does not have
a sharp contrast against surrounding healthy epithelium, and this type of lesion is frequently
associated with malignancy [74]. Endoscopically, an ALM lesion has features similar to
spontaneous protruding adenomas that are observed in non-IBD patients [74].
In non-IBD patients, for example those with spontaneous polyp (non-cancerous) growth,
the standard procedure is a polypectomy which completely resects the mass [74, 105]. Recent
studies have suggested that polypectomy of an ALM mass in IBD patients is highly successful,
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and could postpone the need for curative colectomy [74, 105]. In contrast, a retrospective study
showed that a higher proportion of unresectable lesions harbored cancer [109]. The
histopathological differences between ALMs and DALMs are subtle and varied, and an accurate
diagnosis determines if the patient will undergo endoscopic polypectomy or surgical colectomy
[74]. The diagnosis must also take into account additional factors such as patient age, duration of
disease, and if the lesion is within the region affected by colitis [62]. The recommendation of an
international consensus in 2005 was to perform four-quadrant biopsies every 10cm, with a
minimum total of 32 biopsies during surveillance [67]. Despite surveillance, between 50% and
80% of DALM lesions are not visible during traditional endoscopy [110].
4.3 Endoscopic imaging of UC patients
In order to improve detection of easily missed lesion, various endoscopic imaging
modalities have emerged to provide additional information during the surveillance of IBD
patients, including chromoendoscopy, narrow band imaging, and laser endomicroscopy [73]. The
first study of chromoendoscopy in IBD patients was published in 2003, in which the colonic
epithelium was sprayed with 0.1% indigo carmine (a colorimetric contrast agent), and the results
showed that three times as many neoplastic lesions were detected via chromoendoscopy than
with traditional colonoscopy [73]. Magnification chromoendoscopy detection of intraepithelial
neoplasia was four times as high as traditional colonoscopy [111]. Narrow band imaging, as
previously described, can image blood vessels and capillary patterns without the need for indigo
carmine or another contrast agent [74, 75]. While these imaging modalities have increased
detection of lesions, they cannot distinguish between ALMs and DALMs, as the image features
are similar [74]. Laser endomicroscopy allows for imaging of cellular and subcellular structures,
providing more detailed imaging of features that relate more closely to histopathological features
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[76]. A combined study of chromoendoscopy and endomicroscopy showed a 4.75-fold increase
in detection of lesions, as well as a 50% reduction in the number of required biopsies [73].
Laser endomicroscopy could describe either confocal or multiphoton laser
endomicroscopy systems, both of which can provide high-resolution depth-sectioned information
on changes in cellular and even subcellular structures. Confocal laser endomicroscopy systems in
studies were dependent on contrast agents, such as the contrast provided by intravenous
fluorescein (a fluorescent contrast agent), and therefore provided images of structure and
morphology based on blood flow patterns [76]. Neoplastic regions predicted by the system were
compared to histopathology and found to be highly accurate (97% sensitivity, 99% specificity)
[76]. In patients with UC, a study showed that the combination of chromoendoscopy and
endomicroscopy increased the discovery of neoplastic regions 4.75-fold [76]. An in vivo case
studied a DALM lesion and adjacent colorectal epithelium, using the Cellvizio ®
Endomicroscopy System (Mauna Kea Technologies, Paris, France), a 2.5mm catheter imaging
probe inserted into an existing working channel during colonoscopy, and 5mL of 10% sodium
fluorescein injected intravenously [112]. Acquired confocal images showed enlarged crypts,
increased irregularity in the distribution of crypts, increased space between crypts, as well as
crypt destruction or fusion [112]. They also showed the transition from inflamed mucosa (due to
ulcerative colitis) to dysplastic mucosa [112]. Inflammation was characterized by enlarged crypt
openings, with leaking of fluorescein into the crypt lumen that appeared as bright regions in the
crypt center, while low-grade dysplastic regions were characterized by dark centers with
irregular structural patterns [112].
Previously mentioned imaging methods, such as chromoendoscopy and confocal imaging
with intravenous fluorescein, require a contrast agent which can have various disadvantages.
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Chromoendoscopy requires topical application of the contrast agent, followed by rinsing, and
there are reports of the contrast agent not homogenously covering all the epithelial surfaces of
interest in addition to the amount of time each of these application and rinse cycles can take
(after applying the contrast agent, there is a 5 minute wait before rinsing) [73]. In addition, these
contrast agents are not targeted to a specific protein or molecule, therefore the images provide
important information on vasculature patterns and morphological structure, but do not provide
more specific cellular information. Narrowband imaging does not require an external contrast
agent, but it also predominately images vasculature patterns. Multiphoton microscopy is capable
of acquiring label-free images of bulk tissue without need for fixation, and rapid 3-dimensional
image acquisition up to several hundred microns [40]. Contrast for fluorescence imaging using
multiphoton microscopy comes from the endogenous fluorescence of cellular molecules such as
NADH and FAD, which have been investigated as providing insight into metabolic information
[34, 35]. Miniaturization of multiphoton laser microscopy systems allows for in vivo imaging,
utilizing the advantages of multiphoton acquisition of functional data without need for a contrast
agent, in combination with using near infrared wavelengths to image tissue at increased depth
[113, 114].
4.4 Second harmonic generation imaging applications
Second harmonic generation (SHG) imaging is an alternative imaging method accessible
when using multiphoton microscopy. The first biological application of SHG imaging was in
1986, investigating the polarity of collagen fibers in rat tail tendons [115]. Collagen type I makes
up much of extracellular matrix (ECM) and connective tissue, and has a history of being
investigated via SHG imaging [113, 116]. Collagen fibers are a nonlinear medium due to their
non-centrosymmetric nature (their crystal structure cannot be inverted without change since it
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does not have a point of symmetry), and the polarization of the fibers can be studied using SHG
imaging [117]. SHG imaging in healthy colorectal epithelium highlights crypt shape, as the
collagen fibers provide structure surrounding the cellular arrangement [118, 119]. Miniaturized
multiphoton microendoscopes have been shown to be capable of SHG imaging of bulk tissue.
Miniaturized multiphoton label-free fluorescence imaging of intact rat tissue has been reported as
early as 2001 [120], with endogenous fluorescence and SHG images of fixed murine tail tendons
acquired in 2009 [121], and in 2011 a 3mm-diameter multiphoton endoscopic probe was shown
to acquire both endogenous fluorescence and SHG images of ex vivo murine tissue (tail, lung,
and colon) [114]. The addition of a SHG imaging channel to multiphoton microendoscopes
would provide supplemental structural information about connective tissue, such as collagen,
tendon, and muscle without the need for contrast agents [122]. Preliminary work on SHG
imaging in a murine CRC model has shown SHG imaging of epithelium as providing data on
collagen structural changes that could be used as early indicators of disease [123].
4.5 Objective
Increasing the ability to distinguish between spontaneous (ALM) and colitis-associated
(DALM) tumors in UC patients could guide clinicians in appropriate treatment. Emergence of
multiphoton endoscopic systems allow for combination of functional and structural data to
improve detection and diagnosis of ALM and DALM regions in UC patients, and a quantitative
study of structural/morphological SHG data in these tumor models had not been documented.
SHG image features could serve as complementary data during multiphoton microendoscopic
imaging, and provide insight on collagen changes during crypt deformation, which could serve a
translatable measure towards detection and distinction of lesions in UC patients.
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5. Specific Aims
Introduction
Early detection of oral and gastrointestinal cancer is crucial in decreasing the risk of
morbidity; if detected early, the 5-year survival rate for oral cancer and colorectal cancer is on
average 82% and 92% respectively [61]. For oral cancer, cellular morphological markers of
cancerous cells include large nuclei and large nucleus to cytoplasm ratio [46]. For colorectal
cancer, there are known changes in morphological structure of crypts – cells organized into
cylindrical structures – such as enlarged crypts and loss of cylindricity [11, 12, 124]. Analysis of
morphological markers, such as nuclear size and crypt cylindricity, is typically performed via
histopathology [9, 12]. Since histopathology requires tissue biopsy or resection, often followed
by sectioning, then staining, one area of investigation has been rapid or in vivo imaging of
morphological markers.
Optical imaging of cellular structures makes use of wavelengths of visible light, distinct
from magnetic resonance (MRI) or high frequency wavelengths (x-ray, CT) [21-23]. Optical
imaging modalities range from inexpensive portable devices to expensive investigational
systems. Many of these systems, both expensive and inexpensive, are being adapted for
integration into existing clinical workflow. Low-cost fluorescent systems can be used to analyze
cell morphology in conjunction with fluorescent contrast agents, while expensive devices are
capable of acquiring contrast from endogenous optical signals in unstained tissue. Analysis of
cellular morphology has the potential of detecting abnormal changes in tissue, such as dysplasia
or cancer, before they are grossly visible. The following aims were designed to address the
investigation and optimization of morphological imaging of epithelial cancers, specifically oral
and colon cancer, for early detection.
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Specific Aim 1: Proflavine as a Contrast Agent for Oral Cell Cytology1
Background: Oral and pharyngeal cancer is the sixth most common cancer worldwide, with two
thirds of cases arising in developing countries [42]. While oral squamous cell carcinoma (OSCC)
is commonly detected during regular physician or dentist visits, as high as 95% of populations in
low-resource settings declare a history of irregular dental visits, increasing the risk for OSCC to
develop to late stages without detection [48].Conventional clinical cytology requires biopsies,
fixing, and staining, and investigators have designed alternative protocols, such as oral rinses and
brushes, which can collect exfoliated oral cells for cytological analysis. For both conventional
and investigational oral cytology, morphological image features guide diagnosis of epithelial
cells, where healthy cells are relatively large with small nuclei while oral cancer cells have a
large nucleus to cytoplasm ratio [46].
Low-cost translational devices for cell cytology have used a variety of contrast agents in
order to analyze morphological markers, including fluorescent contrast agents that have
advantages that include high signal to background, rapid staining, and low cost. The use of
proflavine, a rapid fluorescent vital dye, in cytology of OSCC has not been studied. Proflavine
could serve as an alternative contrast agent for future translational cytological devices.
Objective: Rapid identification of oral cells with large nuclei to cytoplasm ratios using low-cost
fluorescence imaging systems could serve in further development of point-of-care OSCC
screening tools. Proflavine, a DNA-intercalating vital dye, could serve as an alternative contrast
agent for oral cytology screening systems in regions where traditional pathology services are not
readily available.

1

Full manuscript available as Chapter II
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Aim 1: Determine the viability of proflavine as an alternative contrast agent for oral cytology.
Our study qualitatively and quantitatively investigated the utility of proflavine solution in
imaging of exfoliated oral cells for OSCC screening. We examined the potential of proflavine as
a contrast agent for oral cell cytology, using a portable (POC capable) microscope in order to
qualitatively distinguish differences between healthy and cancerous cells, and quantitatively
distinguish morphological differences (specifically nuclear to cytoplasm ratio).
Results: Images of proflavine-stained cells show morphological detail similar to traditional
staining, with bright distinguishable nuclei and granulation (keratohyalin). Quantification of
nuclear to cytoplasmic ratio in the images showed significantly (p < 0.001) larger ratios in OSCC
cells compared to normal cells, where OSCC cell ratios averaged above 0.8 compared to normal
cell ratios averaging below 0.1.
Significance: Our comparison of nuclear to cytoplasmic ratios could help guide future POC
imaging system design for low-resource oral cytology screening. Quantitative analysis of image
features in oral cell cytology using proflavine had not been investigated. Future studies could use
one-step proflavine staining to qualitatively inspect cells, or computer-aided image segmentation
could be implemented to measure nuclear size and create rapid analysis of exfoliated oral cells.
Specific Aim 2: Image feature quantification and alternative contrast agent for a
translational microendoscopy system2
Background: Colorectal cancer (CRC) is the second leading cause of cancer death in the United
-States [61]. After resection of the primary tumor, recurrence remains a common outcome;
cancer recurred in 44% of patients, requiring further surgery [70]. Increased screening using
traditional white-light wide-field colonoscopy has led to a decrease in morbidity in the past few
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decades, but it is not an ideal imaging modality for detection of sessile or flat lesions [77-79].
Various techniques have been investigated for surveillance of at-risk patients, including salivary
protein markers, but endoscopic imaging systems have several advantages [71]. Endoscopic
imaging systems analyze cellular and crypt morphology, which pathologists are trained in
identifying. In addition, conventional colonoscopy already has clinical protocols and physical
tools in place for endoscopic imaging, thereby facilitating translation of these imaging systems
into in vivo clinical settings [72].
Microendoscopic imaging systems have been studied in CRC patients and quantitative
analysis of a clinical fluorescence microendoscopy images using proflavine as a contrast agent
has shown up to 98% specificity in diagnosis of neoplastic polyps [86]. In vivo clinical diagnosis
was made on morphological image features based on crypt morphology, including nuclear
organization and epithelial thickness [86]. Viability of automated quantification of these image
features, specifically crypt size and circularity, in microendoscopic images has not been studied.
Objective: Automated quantitative analysis of morphological features in microendoscopic
images can provide an objective method of distinguishing between normal and neoplastic
regions. Complementary microendoscopic-level information can be included into traditional
colonoscopy workflow, as demonstrated by various studies, and can increase detection of
neoplastic lesions at an early stage, with automated quantification minimizing user effort and
bias. The use of fluorescein, currently approved for intravenous use in certain clinical
applications, in conjunction with these microendoscopic systems could provide investigators an
alternative contrast agent with similar quantitative results for translation into in vivo study.
Aim 2: Quantification of microendoscopy images toward computer-aided analysis of crypt
morphology in colorectal cancer. Our study investigated the potential of automated
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quantification of crypt size and circularity in microendoscopic images using a custom algorithm.
We tested the algorithm’s ability to quantify images of normal and abnormal colorectal
epithelium, using both proflavine and fluorescein as contrast agents.
Sub-aim 1: Development of a custom algorithm for automated analysis of microendoscopic
image features. Acquired images of ex vivo porcine colorectal epithelium stained with
proflavine, a contrast agent used in clinical studies, for development of a custom algorithm for
automated image segmentation and quantification of crypt size and circularity. Quantitatively
compared preliminary data from freshly resected clinical colorectal tissue.
Sub-aim 2: Determine the viability of fluorescein as an alternative contrast agent for
microendoscopic imaging. We tested our previously developed algorithm on images of
fluorescein-stained ex vivo human and animal epithelium, to determine the feasibility of using
fluorescein as an alternative contrast agent in microendoscopic imaging. We compared crypt
detection sensitivity of the automated algorithm in proflavine versus fluorescein stained normal
and abnormal colonic epithelium.
Results: Our custom algorithm showed above 80% crypt detection sensitivity using images of
proflavine-stained freshly resected porcine and human epithelium. Preliminary comparison of
normal and adenomatous diagnoses in human epithelium showed increased crypt area and
circularity in adenoma-adjacent regions. The custom algorithm yielded better crypt detection
sensitivity (>90%) using fluorescein, an alternative contrast agent for microendoscopic imaging.
Preliminary results using fluorescein in ex vivo clinical specimens showed a decrease in average
crypt size in regions of adenocarcinoma when compared to normal regions.
Significance: Microendoscopic imaging has been qualitatively investigated as a potential
intraoperative aid during surveillance colonoscopy, but quantitative analysis of crypt
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morphology as biomarkers of carcinoma had not been documented for this system. Our results
could guide implementation of automated quantification in microendoscopic system design,
including image features such as area and circularity which resulted in significant differences
between normal and cancerous regions. The use of in vivo automated quantification could be
further studied for future translation into clinical settings during CRC surveillance. In addition,
the use of intravenous fluorescein as an alternative contrast agent for confocal endomicroscopy
imaging systems has been studied, but our results show that topical application is a viable
alternative for microendoscopic imaging [112, 124].
Specific Aim 3: Second harmonic generation imaging of murine epithelium for crypt
morphology image feature analysis of spontaneous and colitis-associated colorectal tumors3
Background: Spontaneous polyp, and subsequent tumor, formation accounts for a majority of
CRC cases, with polypectomy (local resection of polyps) a standard treatment [74, 105]. A
smaller percentage of CRC cases have a history of ulcerative colitis (UC), one of two major
types of inflammatory bowel disease, which is linked to increased risk for CRC [94, 98]. Often,
the end-treatment for UC patients is curative colectomy, yet this treatment is deferred until
deemed necessary due to the presence of malignancy [62, 105]. Studies have shown that in UC
patients there is still a distinction between spontaneous tumors, which can be resected via
polypectomy with limited risk of recurrence, and colitis-associated tumors require curative
colectomy [74, 105].
Various translational imaging modalities have been applied to the task of distinguishing
between spontaneous tumors (adenoma-like mass or ALM) and colitis-associated tumors
(dysplasia-associated lesion/mass or DALM) [74]. Endoscopic systems capable of in vivo

3

Full manuscript available as Chapter V
29

imaging of colorectal epithelium include miniaturized confocal systems, such as the Cellvizio ®
Endomicroscopy System [112], and investigational multiphoton systems. Benefits of
multiphoton imaging, miniaturized for endoscopic applications, include label-free imaging (no
need for contrast agents) and the ability of acquiring data of both functional (autofluorescence)
and structural (second harmonic generation) biomarkers [113, 114]. As previously described, in
early cancer development, crypt structures become non-homogenous in size and shape, but the
use of second harmonic generation (SHG) imaging of crypt morphology, via collagen structures,
has not been quantitatively investigated.
Objective: Increasing the ability to distinguish between spontaneous (ALM) and colitisassociated (DALM) tumors in UC patients could guide clinicians in appropriate treatment.
Emergence of multiphoton endoscopic systems allow for combination of functional and
structural data to improve detection and diagnosis of ALM and DALM regions in UC patients,
and a quantitative study of structural/morphological SHG data in these tumor models had not
been documented. SHG image features could serve as complementary data during multiphoton
microendoscopic imaging, and provide insight on collagen changes during crypt deformation,
which could serve a translatable measure towards detection and distinction of lesions in UC
patients.
Aim 3: Determine utility of SHG imaging in investigation of morphological changes in murine
colonic crypt structure in spontaneous and colitis-associated tumor progression. We used SHG
imaging in murine CRC models to analyze data on structural changes in cryptal collagen that
could be used as indicators of disease.
Sub-aim 1: Quantitative comparison of morphological image features in ALM and DALM
murine models. We used SHG imaging to acquire and quantify data on crypt size, shape, and
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distribution in ALM and DALM murine models, to determine feasibility of using SHG imaging
as a complementary source of data using miniaturized multiphoton systems. We sought to
determine which image features held the most potential for distinguishing between ALM and
DALM regions.
Sub-aim 2: Quantitative comparison of morphological image features in early and late time
points of tumor development. We compared SHG image features in early and late time points in both
ALM and DALM murine tumor development, to determine the potential of SHG imaging in assisting
early detection of CRC.

Results: Our results showed that mean and variance of nearest neighbor (distance between
crypts) and circularity were potential image features for SHG modalities in distinguishing
between Control, ALM, and DALM regions in murine models. Control crypts had smaller
average distance to the nearest neighbor compared to late-stage ALM and early-stage DALM
development, as well as more homogeneous distances between crypts (variance). Preliminary
results showed promise in the nearest neighbor image feature (mean and variance) serving as a
morphological marker for distinguishing between early and late-stage DALM time points in our
murine tumor models. Images of late-stage DALM crypts had lower average nearest neighbors
compared to early-stage DALM.
Significance: Miniaturized multiphoton imaging systems have been used to qualitatively and
quantitatively study functional data acquired via fluorescence channels (e.g. redox ratios and
cellular metabolic response), and studies on collagen fiber density and pattern using SHG
channels in various cancers have been documented [113, 114, 123]. Our quantified SHG image
features, specifically nearest neighbor, showed differences in crypt distribution in ALM and
DALM murine models. This could guide future multiphoton studies of these murine models,
such as in vivo studies to acquire both autofluorescence and SHG data to more thoroughly
31

understand crypt morphological changes in spontaneous versus colitis-associated tumors.
Automated quantification of SHG image features, as a complementary modality during
endoscopic multiphoton imaging, could potentially contribute to more accurate screening and
diagnosis of suspicious lesions and polyps during surveillance of high-risk UC patients.
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Chapter II: Proflavine Hemisulfate as a Fluorescent Contrast Agent for Point-of-Care
Cytology [1]
1. Introduction
Cytology is defined as the study of cells on a microscopic scale with a focus on
morphology and structural distinctions [2]. Considering the many cytological procedures that
depend on visual diagnosis, and distinguishing of structural features such as nuclear size, nuclear
to cytoplasmic ratios, and cytoplasmic features, the field depends significantly on contrastenhancing agents. Clinical cytology is typically performed by sample collection, fixation,
staining, and visual inspection by a trained pathologist. Cytology specimens may include
peripheral blood smears, fine needle aspirations (FNA), bronchial alveolar lavages (BAL), and
oral as well as vaginal/cervical exfoliated cells. Clinical cytology provides complementary
information to more conventional histopathology examination of thin tissue sections made from
solid tissue, particularly when screening for cellular atypia and dysplasia [3].
Common contrast agents used for cytology include conventional hematoxylin and eosin
(H&E), Giemsa, and Papanicolaou (PAP) staining [4, 5]. Fluorescent dyes are also popular
contrast agents due to their high signal-to-background ratios, as well as offering the option for
varying levels of specificity in targeting of molecules and/or structures. Fluorescent contrast
agents do not necessarily need to be as target-specific as immunofluorescent staining. Common
untargeted exogenous fluorescent stains include ethidium bromide, acridine orange, propidium
iodide, and acriflavine hydrochloride / proflavine hemisulfate. Popular stains such as the
fluorescent dye acridine orange are widely used in flow cytometry and cytochemistry
applications which do not require the selectivity of immunofluorescence, such as the lysosome
staining of living blood cells, and in distinguishing between different types of lung cells [6].
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Nucleic acid probes, which do not fall under the category of target-specific dyes, despite their
preferential binding to nucleic acids, are used routinely to determine the ploidy or phase of a cell,
but usually require fixation and permeabilization [7-9]. A common benefit of untargeted
fluorescent stains is the simplicity of the staining process, compared to the hybridization time
and environmental factors, such as temperature and media, required for immunolabeling.
Proflavine, an aminoacridine-derived dye similar to acridine orange, non-specifically stains
cellular structures, as well as preferentially stains cell nuclei. It exhibits fluorescence with a peak
excitation around 460nm and emission around 515nm, with a quantum efficiency of 0.5 [10, 11].
Proflavine can be used to rapidly stain fresh cells due to its small molecular size and amphipathic
chemistry, enabling the molecule to easily pass through the lipid bilayer of the cell and nuclear
membrane [12]. It has been shown to intercalate double stranded DNA, providing strong nuclear
contrast [13, 14]. In addition, proflavine exhibits less prominent staining of cytoplasmic
structures, which can be beneficial for cell classification, allowing for applications in cytological
analysis.
Proflavine has been used clinically since 1917 [15], but its use as a cytological tool isn’t
widespread despite its numerous advantages. Its ability to intercalate DNA has provided many
applications including anti-cancer, anti-bacterial, and anti-viral drugs [16-18]. Common research
applications include endoscopy and microendoscopy imaging, modalities that benefit from
contrast agents that allow for rapid topical staining of intact epithelium, where proflavine is used
as a topical contrast agent for histological analysis [15, 19, 20]. There has also recently been
renewed interest in proflavine for point-of-care diagnostic applications in low-resource settings
due to its physical and chemical stability in solution, lasting at least 12 months under
refrigeration [21].
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In this paper we will demonstrate the benefits of proflavine staining in cytological
samples, including rapid and preferential staining of nucleic structures such as cytosol,
membrane, granules and nuclei. Proflavine’s rapid staining eliminates time-consuming
procedures while retaining the benefits of fluorescence imaging. We have demonstrated
proflavine staining in a variety of cell types, including normal exfoliated oral squamous cells, an
in vitro cultured oral squamous carcinoma cell line (Cal 27), and normal human leukocytes from
whole blood. All proflavine fluorescence images were acquired using a custom-built, costeffective and portable fluorescence microscopy platform. Automated image analysis tools were
used to demonstrate the feasibility of using computer aided diagnostic approaches on proflavinestained cytology specimens.
2. Materials and Methods
Mammalian Cell Culture
CAL 27, a squamous cell carcinoma cell line (ATCC CRL-2095, ATCC, Manassas, VA),
was cultured in Dulbecco’s Modified Eagle Medium (DMEM) media supplemented with 10%
fetal bovine serum (ATCC, Manassas, VA) and 1% Penicillin-Streptomycin (Life Technologies,
Grand Island, NY) and incubated at 37°C in 5% CO2. The cells were utilized up to passage
number four. Before staining, the cells were trypsinized with 0.25% Trypsin-EDTA (Life
Technologies, Grand Island, NY).
Human Cell Collection
All human cells used in this study were collected following written informed consent
from healthy volunteers as part of a protocol (IRB#13-06-759) approved by the University of
Arkansas Institutional Review Board.
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Exfoliated oral epithelial cells were collected through an oral rinse consisting of a 30 sec
rinse to remove food particles and bacteria that were discarded followed by a 90 sec collected
rinse. The cell suspension was filtered through a 100μm cell strainer (Falcon, Bedford, MA) to
remove mucus and washed three times by centrifuging at 200g for 5 min, decanting the
supernatant, and resuspending in phosphate buffered saline (1x PBS, Sigma-Aldrich, St. Louis,
MO). Whole blood was collected using a fingerstick lancet (30 Gauge Ultra-Thin Lancets,
ReliOn, Bentonville, AR). The first drop was discarded [22], and approximately 20μl of blood
was collected using a micropipette.
Papanicolaou Staining of Oral Epithelial Cells
A cotton swab was used to transfer exfoliated oral epithelial cells from the oral cavity to a
clean slide, where it was left to dry completely. Following a conventional Papanicolaou staining
procedure [23], the cells were fixed with 95% ethanol, chromatin stained using Gill Hematoxylin
#1 (Millipore, Billerica, MA), blued with Scott’s tap water substitute (Millipore, Billerica, MA),
cytoplasmic counterstained using Modified OG-6 and Modified EA (Millipore, Billerica, MA),
and cleaned with Xylene. After mounting a no.1 coverslip, the slides were imaged in brightfield
using a Nikon Eclipse Ci microscope (Nikon Instruments Inc., Melville, NY) and a 60x Nikon
Plan Apo VC oil immersion objective (N.A. = 1.40, Nikon Instruments Inc., Melville, NY).
Papanicolaou Staining of CAL 27 Cells
After passaging the CAL 27 cells, the cell suspension, ranging from 600,000–800,000
cells, was centrifuged at 200g for 5 min and the media removed. The cells were resuspended in
1X PBS and washed once by centrifuging at 200g for 5 min, decanting the supernatant, and
resuspending in PBS. A glass slide was prepared by pipetting 10μl of the cell suspension and
using the pipette tip to spread the droplet into a monolayer. The slide was dried completely and
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stained following the same modified Papanicolaou staining procedure described previously. The
slide was imaged in brightfield using the same Nikon microscope and 60x oil immersion
objective.
Giemsa Staining of Blood Smears
A peripheral blood smear was Giemsa stained following standard methods [22]. The
smear was allowed to completely dry before being fixed with methanol for a few seconds. The
slide was then stained with a 10% Giemsa (Alfa Aesar, Ward Hill, MA) solution for 5–10 min.
The slide was rinsed with clean water and allowed to dry before mounting a coverslip. The slides
were imaged with a brightfield microscope (Nikon Eclipse Ci, Nikon Instruments Inc., Melville,
NY) using a 60x oil immersion objective (60x Nikon Plan Apo VC, Nikon Instruments Inc.,
Melville, NY).
Proflavine Staining of Oral Epithelial Cells
The samples of exfoliated cells were washed in PBS three times and incubated in 1%
albumin from bovine serum (BSA, Sigma-Aldrich, St. Louis, MO) for 5 min. The BSA was
removed and the cells were stained with a solution of 0.01% (w/v) proflavine in PBS.
Additionally, to collect immature oral epithelial cells, a cotton swab was used to collect normal
oral cells from a volunteer. The swab was mixed in a 0.01% (w/v) proflavine solution to suspend
and stain the cells. A 10μl sample of stained cells from each collection method was added to a
slide and (no.1) coverslipped. The slide was imaged with our epi-illuminated fluorescence
system using a 40x Nikon Plan Achromat air objective (N.A. = 0.65, Nikon Instruments Inc.,
Melville, NY).
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Proflavine Staining of CAL 27
Passaged CAL 27 cells (up to passage number four) were centrifuged at 200g for 5 min
and the media removed. The cells were washed once with PBS by centrifuging at 200g for 5 min,
decanting the supernatant, and resuspending in 1% BSA for 5 min. The BSA was removed and
the cells were stained with the 0.01% (w/v) proflavine solution. The slide preparation and
imaging was conducted the same as previously described.
Proflavine Staining of Leukocytes
The samples of whole blood were stained at a final concentration of 0.01% (w/v)
proflavine solution. The slide preparation and imaging was conducted the same as previously
described.
Custom Fluorescence Imaging System
Image acquisition was also performed using a custom epi-fluorescence microscope (see
Fig 1) based on a microendoscopy platform previously demonstrated [24]. This system
comprises an LED illumination source at a center wavelength of 455nm (Philips, San Jose,
California) providing approximately 8mW at the sample, a 475nm dichroic filter set (Chroma
Technologies, Bellows Falls, VT) and a 525/40nm bandpass emission filter. The imaging system
used a 40x Nikon Plan Achromat air objective (N.A. = 0.65, Nikon Instruments Inc., Melville,
NY) and a 150mm achromatic doublet tube lens (Thorlabs, Newton, NJ). A Flea 3 USB camera
(Point Grey Research, BC, CA) was used for imaging. The samples were placed on a set of linear
translation stages (Thorlabs, Newton, NJ) for x and y axis translation. This system performs
comparably to any conventional epi-fluorescence microscope equipped with a fluorescein or
green fluorescent protein (GFP) filter set and monochrome camera. Images were taken with no
gain, and with exposure times in the range of 100 to 150 msec. Fluorescence images were
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normalized to ensure equal pixel intensity maxima in all images, in order to compensate for
photobleaching and other uneven illumination artefacts. The histograms were stretched,
assigning the highest pixel value to be at maximum intensity (255 for an 8-bit image) and the
other pixel values were scaled accordingly to conserve the ratios.

Figure 1. Custom epi-fluorescence microscopy system. Comprises a Flea 3 USB camera,
525/40nm bandpass emission filter, 475nm dichroic filter set, 455nm LED light source, 40x
Nikon Plan Achromat air objective and two linear translation stages.
Manual Segmentation for Nuclear to Cytoplasmic Ratio
Images were semi-quantitatively analyzed using ImageJ [25]. Digital images acquired
using our custom microscopy system were hand-segmented using ImageJ to isolate the nucleus
from the cytoplasm. The boundary around the nucleus was traced using the free-hand tool,
measuring the area, and repeating the process for the boundary around the entire cell (see Fig 2).
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The number of pixels within each measured area (nuclear, whole cell) was tabulated. The
cytoplasmic area was then calculated by subtracting the nuclear area from the whole cell. The
nuclear to cytoplasmic ratios were then calculated for each cell. The mean and standard deviation
values of these ratios were computed for both normal oral and Cal 27 cells.

Figure 2. Illustration of manually-segmented oral epithelial cells stained with proflavine. Top
row: Normal exfoliated oral epithelial cells. Bottom row: CAL 27 oral squamous carcinoma
cells. Scale bars = 10μm.
Image texture features used to analyze the images included the calculated standard
deviation of the pixel intensity across the entire image, as well as entropy values. Entropy is an
image texture function in the MATLAB toolbox which examines the entire image for pixel
intensity variation, as a measurement of heterogeneity in an image. Standard deviation and
entropy of one hundred images of each type, normal exfoliated oral squamous epithelial cells and
cultured Cal 27 oral squamous carcinoma cells, were computed, averaged, and tabulated. The
statistical significance for each group (p values) were computed using a two tailed Student’s t
test.
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3. Results
Comparison of Cytologic Features Seen in Papanicolaou and Proflavine Stained Oral Cells
Proflavine stains both cytosol and nuclei in oral cells, yet the two regions are still
distinguishable. As seen in Fig 3, Papanicolaou stained cells are compared with similar cell types
stained with proflavine. Nuclear as well as cytoplasmic shape, size, granulation (keratohyalin)
and the golgi zone are distinguishable in both the colorimetric and fluorescently stained cell
types (Fig 4). Note the small, well-defined nuclei in normal oral cells, which exhibit significantly
brighter fluorescence than the surrounding cytoplasm. Cytoplasmic detail, such as keratohyalin
granules, is also apparent. Cal 27 oral squamous carcinoma cells, by comparison exhibit very
large and somewhat undefined nuclear envelopes and prominent Golgi zones. In both cases,
proflavine fluorescence and Papanicolaou staining patterns are similar.

Figure 3. Visual diagnosis comparison of Papanicolaou and proflavine-stained normal oral cells
and CAL 27 cell line. First row: Papanicolaou stained normal oral cells. Second row:
Papanicolaou stained CAL 27 cells. Third row: Fluorescent images of proflavine stained normal
oral cells. Fourth row: Fluorescent images of proflavine stained CAL 27 cells. Scale bars =
10μm.
51

Figure 4. Comparison of cellular features seen in Papanicolaou (top row) and proflavine (bottom
row) stained cells. Left column, oral squamous epithelial cells. Right column, Cal 27 squamous
carcinoma cells. NU: Nucleus, NO: Nucleolus, KH: Keratohyalin granule, GZ: Golgi zone. Scale
bars = 10μm.
Comparison of Cytologic Features Seen in Giemsa and Proflavine Stained Human
Leukocytes
As seen in Fig 5, while Giemsa stains both erythrocytes and leukocytes, proflavine
preferentially stains the nuclei-containing leukocytes. Proflavine, given its ability to intercalate
DNA, prominently highlights nuclear structures within cells. Since human erythrocytes have
little DNA content, there is very little proflavine signal present from these cells. While the
erythrocytes are not visible with proflavine staining, the monolobar and multilobar structures
within leukocytes are clearly distinguishable. Proflavine stained neutrophils exhibit classic
multilobar architecture, with detectable granulation in the cytoplasm. Proflavine stained
monocytes display a smooth, convoluted nuclear envelope and relatively homogeneous
cytoplasm. Proflavine stained lymphocytes are easily distinguished by their characteristically

52

smaller size, and display a relatively heterogeneous chromatin staining pattern and scant
cytoplasmic labeling.

Figure 5. Giemsa (top row) and proflavine (bottom row) stained leukocytes. First row, Giemsa
stained neutrophil (A), monocyte (B), lymphocyte (C). Second row, proflavine stained neutrophil
(D), monocyte (E), lymphocyte (F). Images were captured at 60X. Fluorescence images were
normalized as described in the Methods section. Scale bars = 10μm.
Morphology and Quantitative Image Analysis of Oral Cells
Cytology images were analyzed quantitatively to extract important metrics indicative of
cellular morphology. Both manual image metrics and automatic image texture analysis were
used. Using ImageJ, the ratio between nuclear and cytoplasmic area was computed for
comparison between normal human oral squamous cells and cultured Cal 27 oral squamous
carcinoma cells. Using automated image texture analysis, we also report the use of entropy- a
statistical measure of the randomness of pixel intensity within an image- to characterize images
of proflavine-stained oral cells.
Manual Segmentation for Nuclear to Cytoplasmic Ratio
The nuclei and cytoplasm of 100 normal cells and 100 CAL 27 cells were manually
segmented and measured in ImageJ. Mean and standard deviation values for nuclear to
cytoplasmic ratio were computed as described in the methods section. These results can be seen
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in Fig 6. Note that the nuclear to cytoplasmic ratio of normal oral cells was significantly smaller
than the ratio of Cal 27 oral squamous carcinoma cells. This is expected when comparing
normal, mature exfoliated oral squamous cells to in vitro cultured oral squamous carcinoma
cells.

Figure 6. Bar plot comparing nuclear to cytoplasmic ratios for normal and CAL 27 cells. P value
<< 0.001 with Student T test. Error bars denote standard deviation.
Image Texture Analysis
The same 200 images used to calculate nuclear to cytoplasmic ratios were analyzed using
automated image texture analysis. The texture of each image was quantified individually using
standard deviation and entropy. The difference in mean standard deviation and mean entropy
values for each cell type were statistically significant (Fig 7). The average entropy (measure of
pixel intensity randomness) values for the cultured CAL 27 carcinoma cells were significantly
larger than the normal exfoliated oral cells. Similarly, the standard deviation of pixel values in
the CAL 27 images were significantly larger than the normal exfoliated oral cells. These results
imply that the internal texture, or variation in pixel intensity values within the image of each type
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of cell, is significantly greater in the Cal 27 cells when compared to the normal oral squamous
cells.

Figure 7. Bar plot comparing features between normal and CAL 27 cells. For both plots, p value
<< 0.001 with Student t-test. 100 cells per group. Error bars denote standard deviation.
4. Discussion
In this manuscript, we have demonstrated that proflavine can be used to rapidly stain
fresh cells for cytologic analysis. Proflavine is an effective fluorescent contrast agent for
exfoliated oral squamous cells, highlighting nuclear and cytoplasmic structures, including
keratohyalin granules in mature cells. Structural definition in proflavine-stained cells is
comparable to Giemsa or Papanicolaou staining. As opposed to the multi-step procedure of
Papanicolaou staining, proflavine staining requires only the addition of the dye to the cell
medium before mounting on a slide, eschewing the need for fixation. Giemsa is also a
conveniently applied cytologic stain for hematology specimens, but lacks the benefit of the high
signal to background ratios that fluorescence imaging provides. Compared to traditional
pathology stains, proflavine is cost-effective, requires little setup and materials, and does not
require lengthy staining time (see Table 1). Additionally, proflavine can rapidly stain freshly
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collected leukocytes, clearly showing the multilobar structure of granulocytes in contrast to other
cellular components. Finally, fluorescence images of proflavine stained cells can be analyzed
quantitatively to highlight statistically significant differences in cell types based on morphologic
features.

Table 2. Comparison of proflavine and PAP stained oral cells.
Proflavine

Giemsa

Diff-Quik

H&E

Cost/Slide (materials only)

Estimated $0.50

Estimated $1.00†

$1.50 [26]

$3.39 [27]

Time/Slide Unit Value*

Estimated 1 min

14 min [28]

10-30 min [26]

1.5 min‡ [28]

*Not including time required to examine a slide to reach a diagnosis.
†Based on an average yield of 1000 slides/L.
‡H&E performed with an autostainer.

Normal oral epithelial cells can be classified as basal, parabasal, intermediate, and
superficial. Using our system we have collected mostly intermediate and superficial cells.
Normal superficial cells have a large cytoplasm, with small, well defined nuclei, and small
granules [5]. Cancer cells, due to their high mitotic activity, tend to have enlarged nuclei with
diminished cytoplasm, to the point that the cytoplasm might visibly be a narrow region around
the nucleus, or the nuclei aren’t clearly visible [5]. Of the 100 normal oral epithelial cells stained
with proflavine, all exhibited clearly defined nuclei, while of the 100 cancer cells imaged,
slightly more than half displayed clearly defined nuclei. Proflavine stained cells displayed
comparable cytologic features to PAP stained cells, such as well-defined membranes, nuclei,
granules, and bacteria. Tables 2 and 3 qualitatively compare key image features of proflavine
stained cells with conventionally (PAP or Giemsa) stained cells. Twenty randomly selected
images from each set were visually inspected and evaluated for contrast between features—
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membranes, nuclei, and keratohyalin granules—and the surrounding structures, and each set was
given an overall rating of distinct / strong contrast (++), visible but moderate contrast (+), or
poor contrast / not visible (-), with one feature (the presence of bacteria) classified as N/A for
cultured CAL 27 cells which were intentionally kept free of bacteria (see Table 2).

Table 3. Comparison of proflavine and Giemsa stained leukocytes.

Clearly defined cell membranes (++) were defined as showing a sharp contrast between
the edge of the membrane and the dark background surrounding the cell, while visible
membranes that had indistinct borders were defined as visible but moderate contrast (+). PAP
stained cells were designated as having clearly defined membranes (++) if they showed a sharp
contrast between the bluish-purple edge of the membrane and the white-beige background
surrounding the cell, while membranes that had a color difference but did not have a clearly
defined boundary were defined as (+). As seen in Table 2, PAP stained cells have clearly defined
cell membranes, and proflavine stained CAL 27 cells also had pronounced definition. Proflavine
stained normal cells were labelled with visible with moderate contrast (+) due to some of the
assessed cell membranes having low membrane to background contrast, or having a small gap in
the perimeter, where the membrane was left unstained and the cytoplasm seems to merge with
the background and surroundings. The nuclei, nucleoli, and bacteria were similarly assessed,
with their outer boundary compared against its surroundings (cytoplasm, nucleus, or cytoplasm,
respectively) for strong contrast (fluorescent or colorimetric). CAL 27 cells have large nuclei that
can be difficult to distinguish due to their size and lack of sharp boundaries in both PAP and
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proflavine stained images, whereas their normal counterparts demonstrate high contrast with
both methods of staining. Nucleoli, when visible, appeared with high contrast (++). The Golgi
zone lacked the sharp boundaries of other features, and was defined as clear (++) when the area
was a different intensity or color from the rest of the cytoplasm, visible but unclear (+) when
there was a difference in the area surrounding the nucleus but difficult to tell where the Golgi
zone ended and the cytoplasm began, and unclear (-) if the Golgi zone was not apparent, with
proflavine showing a greater contrast in CAL 27 cells, but not distinguishable in either stain in
normal oral cells.
Whole blood from healthy volunteers was also imaged, and classified by an expert
pathologist (SGS). Features highlighted by proflavine staining, specifically the shape and
number of lobar structures in the nuclei of neutrophils, could be used to classify leukocyte types
[29]. Features such as lobar structure and membrane definition were comparable to Giemsa
stained whole blood, with the primary difference being that erythrocytes are nearly invisible in
proflavine fluorescence images. Randomly selected images from each set were assessed for
features such as lobar structure, membrane definition, and lobar texture (see Table 3). Lobar
structure and membrane was defined as high contrast (++) when the outer boundary was in sharp
contrast with its surroundings, and the shape of the lobes or membrane were easy to identify.
Both Giemsa and proflavine stained leukocytes showed clearly defined lobes, and did not require
use of the visible but moderate contrast (+) label. Proflavine stained leukocytes had a higher
tendency to have diffuse membrane boundaries (-), though they were clearly different from their
surroundings. Lobar texture was assessed by looking at contrasting regions within the lobes
themselves; areas within the same lobes can be in contrast (fluorescent or colorimetric) with
neighboring regions. High contrast lobar texture (++) was defined as distinct patchy contrasting
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regions within lobes, while the lobe texture was deemed to have moderate contrast (+) if there
was little diffuse contrast within. Lobes without internal contrast (-) were commonly due to stain
saturation and were rare in both Giemsa and proflavine stained leukocytes. In summary,
proflavine stained cells displayed comparable cellular features to PAP and Giemsa stained cells,
with less membrane definition overall due to the preferentially nuclei staining nature of
proflavine, but no significant loss of features that would limit cytological classification.
Our study included only a select set of examples of quantitative image analysis of
proflavine stained cells. We have shown that quantification of morphological features of normal
oral, abnormal oral, and leukocytes is achievable using proflavine-staining cytology.
Computational classification algorithms have been previously used in conjunction with imaging
to provide additional tools for the pathologist [30]. Such algorithms could be implemented in
cytological analysis of proflavine-stained leukocytes, using a combination of image texture and
automatically-segmented structural features. Quantitative image analysis could be useful as an
adjunctive tool when analyzing cytology specimens which are ambiguous. Additionally,
computer-aided analysis could allow for diagnosis in the absence of an expertly trained
pathologist. Computer-aided diagnostic platforms are currently in use, including image
segmentation and analysis systems like the CytoSavant and the CellSearch system (specifically,
CellTracks Analyzer) [31, 32]. Additional image analysis platforms and systems have been either
implemented, or heavily researched, such as image analysis of ultrasound data [33-35].
As a research tool, proflavine staining could enable quantitative morphologic
comparisons between many different cell types, while simplifying current imaging lab
procedures. Proflavine fluorescence is compatible with conventional fluorescein isothiocyanate
(FITC)-equipped microscopy tools, and could potentially be introduced as a label in flow
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cytometry. Other methods of flow cytometry / image cytometry include classification of
lymphoblastic leukemia using specific cell surface markers through immunofluorescent labeling
[36]. Non-specific dyes such as propidum iodide and FITC have been used in combination to
distinguish contours, such as the nuclei, and can approximate the accuracy and sensitivity of
“advanced flow cytometers” [37].
Proflavine, as an aminoacridine derivative, is a promising contrast agent for point-of-care
cytology due to its rapid uptake, highly simplified staining procedure, and robust and consistent
staining of cellular structures. Other aminoacridine derivatives, such as acridine orange- with a
peak excitation wavelength of 450 and emission of 650- have also been widely studied as a
nucleic acid stain [38]. Acridine orange has also been studied for point-of-care diagnostics, such
as malaria, due to its rapid and selective staining and high contrast images of intracellular
plamsmodium parasites [39, 40]. Cost-effective point-of-care cytology is currently of high
interest to the biomedical research community, especially for applications in rural or developing
regions. Cell phone imaging technology has been developed and is still being investigated. For
example, an inexpensive white blood cell density counter prototype measured fluorescence in
leukocytes stained with Syto16, a fluorescent nucleic acid stain that required a 30 minute
incubation period [41]. We propose that proflavine can be used as a fluorescent structural dye
across a wide range of unfixed cytology and solid tissue specimens. Using proflavine in
combination with current point-of-care diagnostics, including portable microscopy platforms,
microendoscopy devices and lab-on-chip technology, could prove beneficial in reducing time,
procedure, and cost of screening diseases such as cervical cancer [24, 42-44].
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Chapter III: Quantitative analysis of ex vivo colorectal epithelium using an automated
feature extraction algorithm for microendoscopy image data [1]
1. Introduction
Colorectal cancer (CRC) is currently the third leading cause of cancer death in the United
States, despite increased screening rates and a concomitant decline in incidence and mortality [2,
3]. CRC commonly arises from adenomatous polyps, some of which may progress into invasive
adenocarcinomas over time [4]. This progression is thought to be slow and is dependent on the
size and histology of the polyp [5]. Screening for colorectal polyps via conventional white light
colonoscopy has had a dramatic effect on reducing the overall morbidity and mortality due to
CRC, as visible polyps can be safely removed during this procedure [6]. However, small lesions,
sessile (i.e., flat) lesions, or regions of occult dysplasia can be occasionally missed. A broad
range of alternative strategies have been recently employed to improve endoscopic screening
methods, including autofluorescence endoscopy with real-time image processing, narrow band
reflectance imaging, and combined multimodal methods [7-9]. While these approaches have
demonstrated improved sensitivity for early detection of neoplasia, false positive rates remain
elevated, limiting widespread adoption of these methods for screening purposes [10].
High-resolution endoscopic imaging modalities have been widely explored to improve
detection of these focal regions of early dysplasia in gastrointestinal epithelium [11-14]. Laser
scanning confocal imaging methods employing novel miniaturized distal scanning mechanisms
based on microelectromechanical systems have been demonstrated to yield excellent lateral and
axial spatial resolution [15-17]. Clinical trials of a hybrid endoscope/miniaturized laser scanning
confocal microscope system have demonstrated utility in diagnosing focal regions of dysplasia in
the setting of Barrett’s esophagus and during colonoscopy [18]. These systems offer real-time,
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histology-level information to be displayed to the clinician at the time of endoscopy, potentially
greatly improving biopsy targeting to locations most likely to show evidence of dysplasia [19,
20]. Nonscanning, wide-field fiber bundle microendoscopy methods have also been
demonstrated to yield high-resolution image data from the superficial epithelium with promising
diagnostic accuracy despite the limited field of view [21], restricted by the biopsy port
(∼2mm∼2 mm) through which these devices are deployed in vivo. While certain technical
challenges that remain before microendoscopy methods may be widely disseminated in clinical
applications, the combination of improved wide-field endoscopic methods and high-resolution
microendoscopy methods may greatly improve upon currently achieved accuracy [21, 22].
Furthermore, although several clinical trials of a high-resolution fiber bundle
microendoscopy device have demonstrated excellent interobserver agreement in interpretation
and classification of fiber bundle microendoscopy images of colorectal polyps [21], there is
currently no widely accepted, quantitative image analysis criteria that can be used to objectively
classify fluorescence image data of colorectal polyps without human intervention. Previously
demonstrated interobserver agreement of microendoscopic image interpretation is dependent on
highly trained staff and physicians. This need for high levels of training can be limiting to the
dissemination of microendoscopic screening devices, and quantifiable image analysis criteria is
an option to grant unspecialized practitioners the tools for consistent diagnosis at a reduced
burden of training.
Quantitative image analysis applied in other microendoscopy studies include texture
features of ovarian cancer confocal microendoscopy, cell density in mouse model sarcomas
using wide-field structured illumination, and wavelet decomposition in color colonoscopic video
frames [23-25]. These algorithms quantify a range of image features, such as texture (including
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spatial-frequency content), cell nuclei image segmentation and counting, and discrete wavelet
transform and covariance [23-25]. There are numerous image features that could be extracted for
quantification, depending on the data acquired by the imaging modality, but for the
quantification of image features in fluorescence microendoscopy of nonspecific staining of bulk
tissue, we chose image features that trained clinicians would typically consider in their analysis,
namely crypt shape, size, and homogeneity. Pathologists who study en face histopathology of
colorectal tissue for signs of dysplasia take into account image features such as elongated or
branched crypts, clusters of crypts or crypts of abnormal size, irregular contours, and
stratification of the nuclei surrounding the crypt. While pathologists commonly use nucleic
patterns as a marker for abnormality, due to the length of the colorectal tract, it is of greater
relevance during microendoscopic screening to use a fiber bundle with a larger field of view than
to acquire images that resolve individual nuclei. Therefore, the algorithm we developed focuses
on quantifying the larger structures of epithelial morphology such as crypt area and circularity.
Additionally, the extent to which image morphology varies in clinically normal colorectal tissue
in patients with different clinical histories, such as diagnosis, chemotherapy, radiation, prior
surgeries, or other therapy, has not been described or quantified. There is a significant need for a
quantitative benchmark for future detection of occult dysplasia in patients who have a range of
diagnoses and/or prior treatment, and a need for generalized image analysis tools for advanced
microendoscopy imaging modalities within the gastrointestinal tract.
Any quantitative image analysis algorithm must be able to exclude motion-blurred or
other low-quality images; this is of particular concern in the demanding environment of an in
vivo endoscopy procedure. Approaches such as microarray image processors have demonstrated
that the inherent variability in signal-to-background ratios is correlated with image quality [26].
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Low signal-to-background intensity ratios can affect the ability of an algorithm to accurately
detect image features, and qualitative image exclusion via manual inspection may introduce
human bias and additional error. While some microendoscopy images may be significantly
distorted, the parameters for excluding low-quality images for machine detection by observation
alone may vary in accuracy when compared to a quantitative threshold based on a standardized
metric.
The objective of the study presented in this paper is to explore the quantification of
microendoscopy images in the clinically normal appearing tissue surrounding grossly visible
lesions in recently resected colorectal specimens, in order to extract key differences that may be
used to classify benign epithelial tissue from dysplastic tissue in future computer-aided
diagnostic algorithms. We present both a quantitative image quality control algorithm to exclude
low-quality images, as well as an intensity-adaptive quantitative image feature extraction
algorithm (QFEA) to segment and quantify crypt morphology in images of superficial colorectal
epithelium acquired via fiber bundle microendoscopy. Both algorithms were first validated using
an extensive training library constructed from image data acquired from fresh porcine colorectal
epithelium, a tissue histologically similar to human colorectal epithelium. In addition to
individual image acquisition, consecutive images were acquired for mosaicking, to demonstrate
the ability to improve the inherently small field of view in fiber bundle microendoscopy images,
one prominent disadvantage of microendoscopic systems, using image registration of
consecutive fields of view [27]. All individual images, and several mosaics, collected from
human specimens were then analyzed for quality and subsequently quantified using QFEA.
Images were analyzed to segment crypts within the superficial epithelium, and a centroid map
was created for identified crypts. From each of these maps, quantitative features were calculated,
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focused on crypt-specific properties such as crypt area and circularity. While these metrics were
calculated for proflavine fluorescence fiber bundle microendoscopy, this method could be
broadly applied over a range of high-resolution microendoscopy imaging modalities.
2. Materials and Methods
2.1. Fiber Bundle Microendoscopy System
The microscopy system used has been described previously [1, 28] and comprises a blue
light-emitting diode light source (455 nm, Philips) producing 0.5 mW at the sample, a filter set
(Chroma Tech) with a 525/40nm emission bandpass filter, a 460 nm shortpass filter, and a
dichroic mirror with a cutoff wavelength of 475 nm, a camera [Flea 3 (USB 3.0), Point Grey
Research Inc., California], a 10x objective (NA 0.25, Olympus, Japan), and a customized fiber
bundle image guide with a 1 mm active area diameter (FIGH-50-1100N fiber, Myriad Fiber
Imaging Tech. Inc.). The fiber bundle image guide has custom SMA connectors on both ends; on
the distal end, a modified SMA connector’s rounded edges reduce the friction between the fiber
bundle and the epithelial tissue for smoother continuous image acquisition, as well as protecting
the glass surface from chipping.
2.2. Porcine Tissue
Microendoscopic images of freshly resected colonic porcine tissue were acquired, in
collaboration with Siloam Springs Processing (Siloam Springs, Arkansas), a local
slaughterhouse. One hundred images were acquired from four healthy animals for training
validation of both the quality control and quantitative feature extraction algorithms. These
images were acquired from regions ∼5cm in length, with an average of 30 images acquired per
region. Porcine colorectal epithelium, histologically similar in structure and scale to human
colorectal epithelium, has been previously used as a human analog in myriad imaging studies
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[29, 30]. Figure 1 shows a comparison of normal porcine and normal human colorectal tissue
using microendoscopic and histopathology images.

Figure 1. Normal human versus normal porcine colorectal epithelial tissue. (a) and
(b) Microendoscopy images; scale bar is 100μm. (c) and (d) Histopathology images; scale bar
is 100μm. (a) and (c) Normal human colorectal epithelium. (b) and (d) Normal porcine colorectal
epithelium.
2.3. Human Subjects
Microendoscopic images of freshly resected human colorectal tissue were acquired in
collaboration with the University of Arkansas for Medical Sciences (UAMS) in Little Rock,
Arkansas, following informed consent of each subject per Institutional Review Board standards
at both institutions (IRB #13-06-759 University of Arkansas, Fayetteville, IRB #202224 UAMS).
A total of 10 subjects were recruited for this study, with two subjects excluded due to lack of
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images of clinically normal regions. Thirty-nine microendoscopic images were used to quantify
the image segmentation algorithm’s crypt detection sensitivity. Twenty-eight of these images
were used for quantification (after exclusion due to image quality, as described in Sec. 2.5). For
each human specimen, all microendoscopy images were acquired from a region ∼2cm in length,
with an average of 15 images acquired per region. Participation was limited to both male and
female subjects over the age of 18 with known or suspected colorectal dysplasia or cancer, and
were scheduled for either endoscopic or surgical resection of abnormal tissue. Informed consent
was performed on each subject prior to scheduled surgery.
2.4. Microendoscopy Image Acquisition
Upon receipt of the freshly resected porcine tissue, the colon specimen was longitudinally
sectioned and cleaned using cold saline. Microendoscopy images were acquired immediately
following topical application of proflavine (0.01% w/v in 1x phosphate buffered saline) with a
cotton swab to epithelial surface, with occasional reapplication of dye after several minutes as
needed. Individual images were acquired by manually placing the distal end of the fiber bundle
in contact with the epithelial surface of the tissue; consecutive images were acquired by slowly
dragging the distal end over the epithelial surface for subsequent processing into mosaics.
Sequential image stacks were acquired over 10 to 20 s (covering ∼1 to 2 cm of epithelium), and
all images were acquired in the range of 100 to 150 ms exposure and 0 to 5 dB gain. At the
conclusion of the imaging study, porcine tissue was placed in 10% formalin for fixation
overnight, prior to paraffin embedding, sectioning, and hematoxylin and eosin staining.
For human subject imaging, the resected colorectal tissue was first longitudinally sectioned and
then pinned onto a paraffin block. Additional pins were placed 2 cm apart at regions of interest,
and images were acquired along a linear path between the pins. Microendoscopy images were
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acquired immediately following topical application of proflavine (0.01% w/v in 1x phosphate
buffered saline) with a cotton swab to epithelial surface, with occasional reapplication of dye
after several minutes as needed. Individual images were acquired by manually placing the distal
end of the fiber bundle in contact with the epithelial surface of the tissue; consecutive images
were acquired by slowly dragging the distal end over the epithelial surface for subsequent
processing into mosaics. Sequential image stacks were acquired over 10 to 20 s (covering ~1 to
2 cm of epithelium), and all images were acquired in the range of 100 to 150 ms exposure and 0
to 5 dB gain. For each specimen, typically one to two regions were imaged and sectioned for
histopathology confirmation. After imaging, the study pathologist (K.L.) sectioned the tissue
along the path marked by the pins, which facilitated the correlation of histopathology to
microendoscopy (Fig. 2).

Figure 2. Examples of tissue preparation, microendoscopic image, and histopathology.
(a) Freshly resected gross tissue, pinned to paraffin block; white arrows point to pins delineating
imaging location. Scale bar is ∼2cm. (b) Microendoscopic image of untreated normal colon
epithelium. Scale bar is 100μm. (c) Histopathology image of untreated normal colon epithelium.
Scale bar is 100μm. Images have enhanced contrast and brightness for publishing.
Two-centimeter sections of transversely sliced tissue were taken from imaging sites, and
diagnoses provided by a clinically trained gastrointestinal pathologist (K.L.). Tissue was
classified as clinically normal, normal with underlying invasive adenocarcinoma, invasive
adenocarcinoma, or tubular adenoma at each of the imaged sites.
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2.5. Quantitative Image Quality Control
We developed a quantitative image quality control algorithm to exclude low-quality
images prior to image quantification, based on crypt-specific signal-to-background ratio. This
signal-to-background is based on the contrast between the signal intensity within each crypt and
the surrounding region; the crypt should be darker than the DNA-containing cell nuclei around it.
If the ratio between the intensity values in the surrounding region and the intensity values in the
crypt was too low, the algorithm lost sensitivity in image segmentation and quantification
(Fig. 3). The image segmentation and quantification algorithm was applied to images of both low
and high quality (contrast); specifically, the sensitivity and positive predictive value (PPV) of
crypt identification was calculated. Images with low contrast were excluded from pilot study
quantification of crypt image features.

Figure 3. Example of image quality based on signal-to-background contrast. Top row:
microendoscopy image of human epithelium, with superimposed yellow stars marking centroids,
and yellow box labelling the selected crypt; scale bar is 250µm. Bottom row: surface maps of
pixel intensity in region marked by yellow box (top row). Unlabeled axes are in pixels; 100
pixels are approximately 75µm. The respective lowest intensity of each selection was subtracted
from the image arrays, so that the lowest pixel value is zero without altering the differences in
intensity. The same smoothing function applied to the line profiles for quality ratio (QR)
calculation was applied to these image arrays.
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Prior to calculating the contrast (signal-to-background) ratio, which we have termed the
QR, all images were preprocessed to reduce common intrascene variation, which can result from,
e.g., varying amounts of mucosa or variations in staining due to the topography of the tissue. The
algorithm first masked the original images to restrict analysis and image segmentation to only the
active area of the fiber bundle, and then contrast the enhanced images, whereby intensity values
in the image are mapped to new values so that 1% of the image pixels are saturated at the lower
and upper contrast limits (in this preprocessing step, 1% was saturated at zero intensity and 1%
was saturated at 255), serving to standardize the images by utilizing the full range of the intensity
values, before calculating the QR. Images were masked, excluding any values outside a circle
1000 pixels (750μm) in diameter, ensuring only the uniformly illuminated region of the active
area is analyzed. A microendoscopy image collected from a uniformly fluorescent agarose
phantom (2% w/v agarose, mixed with 0.01% w/v proflavine, in distilled water) displayed in the
full range of colors in the colormap demonstrates this process (Fig. 4).

Figure 4. Example of unmasked microendoscopy image. Arrow points to unwanted light from
outside the fiber bundle. The circle is 1000 pixels in diameter and represents the image area after
masking. Image taken of agarose phantom mixed with 0.01% (w/v) proflavine. Scale bar
is 250μm.
To calculate the QR, the image quality control algorithm extracted vertical and horizontal
line profiles (90 total) from the image, at intervals of 40 pixels (Fig. 5). This was done to ensure
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that line profiles would cross the majority of crypts at least once, accounting for the physical
scale of crypts (ranging 75 to 250μm in diameter) and the scale of the pixels at the image plane
(Fig. 5). Each line profile was smoothed to eliminate small intensity variations due to the fiber
bundle pattern itself. This fiber pattern exhibits a spatial frequency of ∼10 pixels; smoothing
eliminates this periodic variation [Figs. 6(a)–6(d)]. Then, local regional minima and maxima
were determined for each line profile, and the ratio between each minimum and its adjacent
maximum was calculated [Fig. 6(e)]. The regional minima and maxima were determined by
comparing regions of eight values (eight-connected neighborhoods) to surrounding values and
outputting a binary map of the values of the local minima or maxima. All ratios within each
image were then averaged to output a single global average QR metric for the
image. Figure 7 shows the flow diagram of steps for preprocessing (image masking and contrast
enhancement) and QR calculation.

Figure 5. Example of typical crypt sizes and chosen grid line spacing. (a) Microendoscopic
image of healthy porcine colorectal tissue. Inset shows a normal crypt with a width of 80 pixels.
Vertical yellow lines represent the grid lines, with spacing of 40 pixels (yellow double-headed
arrow), that are used to calculate QR in the image quality control algorithm. Scale bar is 250μm.
(b) Example of grid structure and spacing used to extract line profiles for QR calculation.
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Figure 6. Smoothing and QR calculation. (a) and (b) Microendoscopy images of flat-field
illumination showing individual fiber artifacts, before and after smoothing is applied. Axes
display distance in pixels; scale bar is 6μm. (a) Prior to smoothing, gaps between individual
fibers (red arrow) display a significantly lower intensity than the fiber active area. Periodic
variation in contrast is more clearly visible in the line plot in (c). (b) After smoothing, the
intensity difference between individual fiber areas and gaps is reduced, visible in the line plot in
(d). (e) Microendoscopy image of normal epithelium and resulting line plot of image intensity;
scale bar is 250μm. Line plot was smoothed and plotted against distance in pixels. Black arrows
point to first set of minimum (trough) and maxima (peaks). All peak-to-trough values in the
image are averaged to yield a global QR value.
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Figure 7. Flow diagram of image preprocessing and quantitative image quality control. The
original image was masked and contrast enhanced; then line profiles were extracted every
40 pixels, in a grid-like pattern. Scale bar is 250μm. The local minima and maxima of each line
profile was extracted, and the algorithm calculated the ratio between each minima and its
adjacent maxima. The global average of the ratios calculated across the image was termed as the
image’s QR.
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In order to demonstrate the effect of QR on image quality and overall automated crypt
segmentation, we performed the automated QR calculation on the entire porcine image data set
(100 images) and human data set (39 images). For each image, in both data sets, the number of
crypts was determined via manual inspection to determine a ground truth value. The average QR
was tabulated against crypt detection sensitivity (see Secs. 2.6.1 and 3.1) to compute the
optimum image exclusion threshold value. The aggregate average sensitivity was calculated by
averaging the sensitivity of all images with a QR greater than, or equal to, the respective QR
value on the xx-axis, further described in Sec. 3.2.
2.6. Automated Segmentation of Crypt Features
QFEA (Fig. 8) was developed to automatically identify and segment each crypt present
within microendoscopic images, and use this segmented map of crypt location to compute
morphologic parameters such as area and circularity (Sec. 2.6.2). The accuracy of the QFEA’s
image segmentation and crypt identification was greatly influenced by the contrast enhancement
applied prior to conversion into a binary image (further explained in Sec. 2.6.1). To increase
sensitivity of image segmentation, fivefold cross-validation was performed using the porcine
(training) data set in order to compute the average detection sensitivity for different contrast
enhancement parameters (Sec. 2.6.2). The selected contrast enhancement contrast limits were
then applied to both porcine and human images for calculation of sensitivity and PPV of images
with various QR values (results in Sec. 3.2).
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Figure 8. Quantification algorithm flowchart. x is the quantified area of each crypt in pixels.
Circularity is defined in Eq. (3). Multiple contrast limits were applied to increase sensitivity.
Scale bar is 250μm
2.6.1. Selection of optimal contrast limits for image segmentation, using porcine image test
data set
As previously stated, all images were preprocessed to reduce common intrascene
variation, by masking and contrast enhancement. Section 2.5 describes the preprocessing contrast
enhancement, which used a lower contrast limit value of 0 and upper contrast limit value of 1,
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hereafter referred as the [0 1] contrast limits. Due to contrast intensity variations in images,
further contrast enhancement is necessary to create a binary image of crypts with acceptable
crypt detection sensitivity. As seen in Fig. 9, intensity-adaptive contrast enhancement was used
to improve overall crypt detection accuracy. Contrast enhancement, which requires selection of
lower and upper contrast limits, scales image intensity values (0 to 255, for our images) between
0 and 1, whereby intensity values in the image are mapped to new values so that 1% of the image
pixels are saturated at the lower and upper contrast limits, as described in
Sec. 2.5. Figure 9 shows the histograms of an original image and images after contrast
enhancement with different contrast limit pairs. Crypt detection is not shown for the original
image, and the image with [0 1] contrast limits, because the image segmentation algorithm
(QFEA) did not detect any crypts (neither true positive nor false positive) for either of these
images. Note that the QFEA detected crypts in the image that was contrast enhanced using the
[0.4 0.9] contrast limits, which were missed by the [0.5 0.9] contrast limits. Contrast limits affect
the ability of the QFEA to recognize and segment crypts in different regions of the image;
therefore, the overall crypt detection sensitivity of the algorithm was increased with the
combination of multiple contrast limit pairs.
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Figure 9. Comparison of image histograms and crypt detection using different contrast limit
pairs. Contrast enhancement requires a lower and an upper contrast limit; three contrast limit
pairs are shown here [0 1], [0.4 0.9], and [0.5 0.9]. The algorithm did not detect any crypts when
using the original image, nor the preprocessed image. Note that the image that was contrast
enhanced using the [0.4 0.9] contrast limits detects crypts missed by the [0.5 0.9] contrast limits,
thereby increasing the sensitivity of the algorithm with the combination of multiple contrast limit
pairs. Scale bar is 250μm.
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To determine the optimal combination of contrast limit pairs for image segmentation, we
iteratively increased the values of the lower and upper contrast limits by 10% (Fig. 10). There
were 36 contrast limit pairs in the range from [0.1 0.2] to [0.8 0.9]. Due to extremely low crypt
detection sensitivity in images with [0 1] contrast limits, the lower contrast limit 0 and the upper
contrast limit 1 were excluded from testing.

Figure 10. Schematic of intensity contrast limit combinations tested for crypt segmentation.
Contrast enhancement scales image intensity values (0 to 255) between 0 and 1, scale bar is
250 µm. Both upper and lower contrast limits were iteratively increased by 10% to cover a range
from [0.1 0.2] to [0.8 0.9]. Gray region depicts unusable contrast limit pairs.
A training data set comprising 100 images, acquired from porcine colorectal mucosa, was
used to assess the ideal intensity contrast limit pairs to optimize crypt segmentation sensitivity.
All 36 upper / lower contrast limit combinations were applied to each image, and the sensitivity
and PPV of each contrast limit pair was calculated using the number of true positive, false
positive, and false negative crypts detected, as compared to manual inspection of the image.
Fivefold cross-validation was used to define test and training sets; one fifth of the data was set
82

aside as the test set, and the remaining four fifths were used to train the algorithm. The algorithm
selected the best contrast limits using the training set, and then those contrast limits were applied
to the test set to calculate crypt detection sensitivity. This was repeated four additional times, so
that each of the five groups served as a test set, and resulting output displayed the selected
contrast limits and the average sensitivity of the five test sets. The fivefold cross-validation
algorithm was repeated 10 times, with the random assignment of images yielding slightly
varying sensitivity averages. Sensitivities of several combinations of contrast limit pairs were
also calculated using the fivefold cross-validation algorithm; selection of these combinations is
described in Sec. 3.1. The average sensitivity, and standard deviation, of each selected contrast
limit pair and combination was tabulated.
2.6.2. Iterative contrast limits and automated crypt identification, segmentation, and
morphology quantification
Using the optimal contrast limit pair combinations (determined using the previously
described process), porcine and human preprocessed (masked and contrast-enhanced as
previously described) individual images and human image mosaics were quantified with QFEA.
The quality control step was not used for the initial analysis, of all porcine and human images, in
order to determine the optimal QR exclusion value. The QFEA contained the list of selected
contrast limit pairs, and passed an image and first set of contrast limits to a quantification
subroutine that returned the coordinates of centroids located, and calculated crypt area and
circularity. These steps were repeated iteratively (see loop in Fig. 8) with five different pairs of
contrast limits, to increase the sensitivity of QFEA. The last step was to save the quantified data
and display the centroids (last step in Fig. 8).
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Using the optimal contrast limit pair combinations selected after fivefold cross-validation
of the crypt segmentation algorithm, as described in Sec. 2.6.1, each of the porcine (100) and
human (39) preprocessed images were converted into a binary image, using a variable threshold
determined by Otsu’s method [31], choosing a threshold that minimizes the variance of black
(value 0) and white (value 1) pixels. The binary image was then eroded, with a disk structuring
element of 5 pixels radius. Erosion, in short, changes binary values to 0 unless the structuring
element, in this case the disk, overlaps only with binary values of 1 when translated to different
positions [32]. Since we are quantifying circularity of relatively circular crypts, our structuring
element is necessarily round and of a radius of 5 pixels since our individual fibers are ∼5 pixels
in diameter.
The resulting binary image was then inverted, with all 1 values converted to 0, and all 0
values converted to 1, and remasked using the field-of-view (FOV) binary image, to ensure that
the crypts are the value-1 binary shapes. Holes were then closed, where if a region of value 0 is
completely enclosed by value-1 pixel, the region is converted into value-1s as well. The resulting
shapes were once more eroded with a disk (5 pixels radius), and the coordinates of centroids of
detected shapes were extracted, hereafter referred to as crypts, as well as each crypt’s area and
circularity. The centroid for each crypt is the coordinates for the center of mass of each shape. In
the eroded binary image, each crypt is defined as a group of continuous value-1 pixel, and the
centroid is determined as the average of those pixel positions based on the equations
(1)

𝐶𝑥 = ∑𝑛𝑖=1 𝑋𝑖 ,

(2)

𝐶𝑦 = ∑𝑛𝑖=1 𝑌𝑖 ,
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where C is the centroid coordinate, (x,y) is the position of a value-1 pixel, and n is the number of
value-1 pixels in the crypt [33]. Crypt area was quantified as the actual number of pixels in the
shape (binary value of 1, in this case). The circularity was calculated using
(3)

𝐶𝑖𝑟𝑐𝑢𝑙𝑎𝑟𝑖𝑡𝑦 =

4𝜋𝐴
𝑃2

,

where A is the area in pixels and P is the perimeter, and a perfect circle has a circularity of 1.
After extracting crypt area, crypt circularity, each crypt was quality controlled to exclude those
larger than 100,000 pixels in area or smaller than 500 pixels in area (areas outside the range of
crypt sizes based on trained observer quantification), or if the circularity was <0.5. This
exclusion eliminated many shapes that were incorrectly labeled as crypts by the iterative contrast
enhancement and erosion steps. Finally, each coordinate was compared against the array of the
previous contrast limit pairs’ centroid coordinates (if applicable), and if any two coordinates
were at a distance closer than 50 pixels, they were considered duplicates and the duplicate
centroid data were not stored. The resulting arrays of crypt area, circularity, and centroid
coordinates, as well as the FOV, were returned to the main function.
2.6.3. Image stack preparation and mosaicking
As described in Sec. 2.4, consecutive images were acquired by slowly dragging the distal
end over the epithelial surface for subsequent processing into mosaics. To develop a mosaic
image, images from each location (image stack) were cleared of duplicates and images with
obvious motion blur. The remaining images in the stack were then preprocessed by masking and
contrast enhancement, as described in Sec. 2.5. The image stacks were then stitched together; our
mosaics consisted of four to six consecutive images stitched together for a final FOV ranging 3
to 5 mm in length and ∼0.7mm in height. Mosaics were created from individual images using a
modified version of an existing algorithm [31], which requires manual input to select pairs of
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matching points on two adjacent images, and then uses bilinear interpolation to assign
appropriate intensity values in spaces created by stretching or shrinking the second image to
match the selected coordinates. Once image stacks were converted into a mosaic, they were
treated the same way as a preprocessed individual image and subject to the image segmentation
algorithm (QFEA).
3. Results
Individual mages for this manuscript were acquired from histologically normal regions of
human and porcine colorectal tissue, as described in Secs. 2.2 and 2.3. One hundred individual
images were acquired from porcine colorectal mucosa as an algorithm training data set and were
used in the selection of the best five contrast limit pairs for image segmentation. Thirty-nine
images of human epithelial tissue used for automated sensitivity quantification were acquired
from clinically normal regions surrounding grossly visible tumors, in excised tissue of eight
patients, five diagnosed with invasive colonic adenocarcinoma, two with invasive rectal
adenocarcinoma, and one with tubular adenoma. Images of human epithelial tissue used for
image mosaicking included both normal and abnormal regions in the same excised tissue of eight
patients. All porcine (100) and human (39) images were used for calculating the relationship
between average image sensitivity and the QR ratio metric, and determining the optimal QR
exclusion threshold value. The images with passing QR were used for quantification of human
crypt features in a pilot study, and each individual crypt, as identified by QFEA, was considered
a separate data point for quantitative comparison. This comparison is not comprehensive,
considering our small sample size, but it shows the ability of QFEA to distinguish variations in
crypt size and circularity. A few mosaics were also qualitatively described, as well as subject to
the image segmentation and quantification algorithm as proof-of-concept.
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3.1. Selection of Optimal Contrast Limits for Image Segmentation, Using Porcine Image
Test Data Set
For improved crypt detection sensitivity during image segmentation, optimal contrast
limit pair combinations were selected using fivefold cross-validation, as described in Sec. 2.6.1.
The average sensitivity at each of the 36 contrast limit pairs (Fig. 10) is shown in Fig. 11(a) as a
heatmap, with color corresponding to the average percent sensitivity at each contrast limit pair.
As described previously, multiple contrast limit pairs increase the sensitivity of
QFEA. Figure 11(b) shows the average of the contrast limits with the highest test sensitivity
(labeled in Fig. 11 as “1”), as calculated via fivefold cross validation, as well as the average and
standard deviation of various combinations of contrast limit pairs. Figure 11(a) shows “1” as the
contrast limit pair with the highest stand-alone sensitivity and “2” as the contrast limit pair with
the second highest sensitivity; combining contrast limit pairs with the same lower contrast limit
(contrast limits labeled “1” and “2” both have a lower contrast limit of 0.5) does not yield as
large of an increase in overall sensitivity of the QFEA as combining the best contrast limit pair
from each row/lower contrast limit (contrast limits labeled “1” and “3”). As seen in Fig. 11(b),
combining the two contrast limit pairs with the highest sensitivity increases the overall test
sensitivity by <15%, but combining two contrast limit pairs with different lower contrast limits
[from different rows in Fig. 11(a)] yields an increase in overall sensitivity of over 35%. A
combination of five contrast limit pairs, the highest sensitivity from each row (lower contrast
limit) from 0.2 to 0.7, yielded the highest overall test sensitivity [Fig. 11(b)] before a plateau in
performance. While adding more than five contrast limit pairs might slightly increase the average
reported sensitivity of QFEA, there is the risk of overtraining the algorithm to be too specific to
the training set.
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Figure 11. (a) Heatmap of the average percent sensitivity for each contrast limit pair; colorbar is
percent sensitivity. As with Fig. 10, the xx-axis displays the upper contrast limit, and the y-axis
displays the lower contrast limit. (b) Average test sensitivity, after 10 iterations of fivefold crossvalidation, for each contrast limit pair or combination of contrast limit pairs. Maximum standard
deviation among all points was <0.61%. Heatmap (a) has numbered the contrast limit pairs
selected for average sensitivity calculation, for clear correlation to the x-axis in plot (b).
3.2. Quantitative Quality Ratio and Crypt Detection Sensitivity of the Image Segmentation
Algorithm
All porcine (100) and human (39) microendoscopy images were quantified (QFEA) using
the five contrast limit pairs selected in Sec. 3.1. The quantitative image quality control algorithm,
described previously, yielded a global QR metric (peak-to-trough ratio) per image, and this
average ratio was tabulated along with the crypt detection sensitivity of QFEA, for each image.
In Fig. 12(a), the sensitivities and PPVs of images with a QR value equal to, or higher than, the
specified QR value (x-axis) were averaged for an aggregate average sensitivity at that QR. The
peak aggregate sensitivity, before the decline, was at a QR value of 1.07 [Fig. 12(a)]. Therefore,
a QR value of 1.07 was selected as the image quality control threshold, excluding for
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quantification any images with a QR of <1.07. QR values >1.1 used <10 images for average
sensitivity calculation, and are not reliable indicators.

Figure 12. (a) Average sensitivity and PPV of the QFEA crypt detection versus the average QR
of images; aggregate performance plotted against QR was calculated using images with QR
values equal to or higher to the QR labeled in the x-axis. (b) Number of images with QR values
equal to or higher than the labeled QR values.
3.3. Pilot Study of Quantified Crypt Morphology
Quantified crypt data were compared between images of surrounding grossly appearing
normal regions in patients grouped as case 1 or case 2; case 1 were patients diagnosed with
invasive adenocarcinoma and case 2 were patients diagnosed with tubular adenoma. For
individual images, crypt area and circularity were significantly greater for the case 2 group than
the case 1 group. The tabulated area and circularity, displayed in Fig. 13 in arbitrary units, were
divided by the maximum data value in area and circularity, respectively. A total number of 10
images with 219 cumulative identified crypts were used for case 1, and nine images with 219
cumulative identified crypts for case 2. A two-tailed Student t-test yielded pp values of <0.01 for
the area, and <0.005 for the circularity.
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Figure 13. Comparison of image features in individual microendoscopic images of clinically
normal tissue in patients grouped as case 1 and case 2. Case 1 had an adjacent region diagnosed
as invasive adenocarcinoma and case 2 had an adjacent region diagnosed as tubular adenoma.
Error bars denote standard error, and p values were calculated using two-tailed Student t test.
Microendoscopy images on the right are examples of quantified images. Scale bar is 0.5 mm.
3.4. Qualitative Image Analysis and Automated Crypt Identification of Mosaics
Mosaics were created from consecutive fields of view to demonstrate the ability to
improve the inherently small field of view in fiber bundle microendoscopy images, and the
image segmentation and quantification algorithm was applied to them to determine if
quantification of the mosaics using our algorithm was viable. Figure 14 shows a qualitative
comparison of image mosaics acquired from both normal and dysplastic regions of colonic
epithelium. The original images were acquired over 10 s, and the new FOV was ∼3.5mm long
and 0.7 mm wide for both mosaics. The mosaics comprise five individual consecutive images.
Normal tissue [Fig. 14(a)] has regularly spaced crypts, surrounded by a pericryptal sheath,
demonstrated here as a bright ring enclosing the luminal compartment (see yellow arrow).
Neoplastic tissue [Fig. 14(b)] oftentimes demonstrates irregularly shaped crypts that are
haphazardly arranged, and the yellow arrows point to crypts that have uneven ring structures
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enclosing them. The crypt detection sensitivity, when applied to the mosaics in Fig. 14, was 70%
[Fig. 14(b)] or higher [Fig. 14(a)].

Figure 14. Image mosaics showing (a) normal colon and (b) invasive adenocarcinoma. Yellow
arrows point to crypts. Images have enhanced contrast and brightness for publishing. Scale bar is
0.5 mm.
Figure 15 shows an occult hyperplastic polyp in otherwise normal-appearing
tissue, ∼1mm in diameter, whose relative size and morphology was highlighted by mosaicking.
A stack of eight images was mosaicked using the method stated previously, with the yellow
arrows [Fig. 15(a)] pointing to the edges of the hyperplastic polyp ∼1mm in diameter. The
imaged region was ∼3mm in length and 0.7 mm in width—the yellow arrows on gross tissue
[Fig. 15(b)] point to the edges of the imaged region. The white arrow [Fig. 15(b)] points to the
grossly visible tumor, which was ∼4cm to the right of the hyperplastic polyp [yellow
arrows, Fig. 15(b)].
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Figure 15. Example of occult dysplasia. (a) Image mosaic showing a hyperplastic polyp. Yellow
arrows point to edges of hyperplastic polyp. Scale bar is 0.5 mm. (b) Context image showing
gross view of colon epithelium and location of image mosaic at left. Yellow arrows point to
mosaic endpoints (∼3mm). White arrow points to cancerous region (invasive colonic
adenocarcinoma). Scale bar is 10 mm. Images have enhanced contrast and brightness for
publishing.
4. Discussion
Fiber bundle microendoscopy images of ex vivo colorectal epithelium contain useful
quantitative data that may be used to assess the tissue microstructure for evidence of occult
dysplasia. In this paper, we have described QFEA, an approach to automated quantification of
important features of colorectal epithelial microstructure from microendoscopy image data. One
hundred images of normal porcine tissue were used to select, via fivefold cross-validation, the
best contrast limit pair combinations for crypt detection sensitivity. In addition, we have also
demonstrated a method to automatically calculate, and exclude, images with low signal-tobackground ratios (QR) in order to filter and remove images that may yield unreliable
quantitative data. In clinical settings, the fiber bundle microendoscopy imaging system used in
this study may acquire image data via manual placement of the probe directly into the epithelial
surface, or remote placement onto tissue during an endoscopic procedure. In both of these
applications, significant image quality variability may occur. The majority of the images
demonstrated a crypt detection sensitivity of >80% following analysis via QFEA, indicating
potentially reliable calculation of quantitative reporters of tissue microstructure.
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A combination of contrast limit pairs was tested with the porcine image data set to
determine the best parameters for high crypt detection sensitivity. While the contrast limits were
iteratively increased by 10%, it is likely that smaller step increases would have provided
increased overall sensitivity. A larger data set would be required to test if smaller iterative
increases and contrast limit selection would generalize for microendoscopy images, or if the
algorithm would be overtrained. The crypt identification algorithm, using the selected
combination of contrast limit pairs, was then applied to both porcine and human images, to
determine the aggregate performance when excluding images with low QR (Fig. 12). As seen
in Fig. 12(b), the number of images, both porcine and human, with QR values >1.1 drops below
20, decreasing sample size and leading to undersampling bias in the calculated sensitivities at
those values. Figure 12(a) reveals that the PPV of human images is drastically lower than that of
the porcine image set. We believe this is due to a more carefully controlled imaging procedure
with the porcine tissue, since image quality of human tissue is influenced by variations in human
preoperative procedures, and sample handling by clinicians and staff. Potential alternatives to
improve image quality include alternative contrast agent or optical sectioning techniques such as
structured illumination [34].
A pilot comparison of quantified crypt morphology (Sec. 3.3) demonstrated the ability of
our quantitative image quality control and image feature extraction algorithm (QFEA) to detect
minor differences between two otherwise clinically normal appearing colorectal tissue
specimens. While a conclusive statement cannot be made based on image data from eight human
patients, it does suggest that an algorithm such as QFEA can quantify crypt features objectively
and without significant user input. Similarly, no definite quantitative statements can be made for
image mosaics, until a larger data set is acquired. Qualitative inspection of the image mosaics
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shows them as a viable method for overcoming the FOV size limitations of microendoscopy,
while image segmentation of the mosaics shows the potential applicability of QFEA to
mosaicked images.
In vivo inspection of gastrointestinal mucosa using high-resolution microendoscopy
methods has been previously shown to yield clinically useful data. Recent studies examining
manual inspection of microendoscopy images of known diagnoses have demonstrated strong
interobserver agreement, indicating that well-trained clinicians should be able to effectively
incorporate these methods into clinical practice [21]. Qualitative assessment of these images by a
highly trained observer is likely to continue to yield clinically relevant data, but widespread
adoption of high-resolution, in vivo, microendoscopy methods for improved detection of occult
dysplasia remains a challenge. A user-independent method of image analysis could provide
additional data to make an informed decision and reduce the burden of training required for the
clinician at the point-of-care. The introduction of an image analysis algorithm like QFEA into
computer-aided diagnostic methods may yield useful complementary data to make improved
clinical decisions. In our pilot study, QFEA demonstrates an ability to detect minor differences
between two otherwise clinically normal appearing colorectal tissue specimens, suggesting that
discriminative quantitative crypt features can be measured objectively and without significant
user input.
Computer-aided diagnostic approaches have been of significant research interest in
myriad cancer detection approaches, including imaging. Automated quantitative classification
has been applied to breast cancer detection using ultrasound images, digitized mammograms, and
histopathology, ovarian cancer detection using matrix-assisted laser desorption/ionization
imaging mass spectrometry, and prostate cancer grading using ultrasound images and
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histopathology [35-40]. Quantitative classification based on microendoscopy image texture
features in Barrett’s esophagus and esophageal squamous cell carcinoma, specifically gray-level
co-occurrence matrices, has been previously investigated [41-43]. A recent publication on
automated selection of high-quality frames in microendoscopic images [44] points to both the
need for quality control, as well as the viability of automated extraction of high-quality frames
during video-rate acquisition. Ongoing development work with microendoscopic systems may
enable spectroscopic data to be used in conjunction with quantitative image features, such as
those described in this paper [45]. This quantitative data, coupled with extracted image-based
features provided by algorithms such as QFEA, could lead to the adoption of standardized,
objective methods of in vivo high-resolution microendoscopy image interpretation and analysis.
In conclusion, the methods described here provide insight into the ability of fiber bundle
based high-resolution microendoscopy imaging tools to yield clinically relevant data about the
tissue microstructure in colorectal epithelium. Effective clinical translation and application of
any quantitative image analysis tools applied to this imaging method will need to account for
some unavoidable image quality variation, particularly for in vivo endoscopic application of the
device on living, constantly moving tissue. Quantitative assessment and control of highresolution image quality is essential to ensuring reliable results in any future objective,
computer-aided diagnostic algorithm development.
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Chapter IV: Fluorescein as a topical fluorescent contrast agent for quantitative
microendoscopic inspection of colorectal epithelium [1]
1. Introduction
Microendoscopy is an emerging method which can provide clinicians with in vivo
information on tissue microstructure that is not readily visible using traditional colonoscopy and
endoscopy. It allows for histology-level detail to be acquired in real-time, with the potential for
in vivo guidance for the clinician, such as in targeted biopsies [2, 3]. Myriad microendoscopic
imaging modalities have been applied to various tissues, including ovarian, esophageal, bladder,
colonic, and oral epithelium [3-8]. We have chosen to investigate colorectal cancer, as it is
currently the second leading cause of cancer deaths in the United States [9]. The precursor of
colorectal malignancy is dysplasia and there is a long lag phase between the onset of dysplasia,
and the development of malignancy [10]. Detecting these regions prior to becoming clinically
evident will further help in preventing colorectal cancer [11]. In addition, patients with
inflammatory bowel disease (IBD), who are frequently screened for dysplastic regions, would
likely also benefit from early detection of suspicious lesions [12]. Several microendoscopy
imaging studies are aimed at improving early detection of glandular epithelial dysplasia, and
providing biopsy guidance and prognostic indicators in clinical settings [3, 13-15].
Currently described microendoscopic methods for in vivo imaging of gastrointestinal
epithelium vary, including integration of the probe into conventional endoscopes [13], fiber
bundle confocal systems for increased depth penetration [2], and portable wide field end-on fiber
bundle approaches such as a previously developed system [5]. End-on fiber bundle systems, such
as the one used in this manuscript, are designed to come into direct contact with the tissue, and
image acquired is either of the tissue directly in contact with the distal end of the probe (for wide
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field microendoscopy systems), or of varying depths below the epithelium (depth-sectioning with
point-scanning systems). Benefits of end-on fiber bundle systems include eliminating the need
for rinsing tissue after stain application to remove excess dye, which is required for alternative
imaging modalities such as chromoendoscopy [16]. Eliminating the rinsing step is possible since
end-on contact reduces specular reflection or unwanted fluorescence, with the additional benefit
of rapid imaging after staining since there is no wait time for sufficient incubation to occur
before rinsing. While a wide field approach does not have the depth-sectioning capabilities of a
point-scanning system, it does not require a pinhole, laser light source and alignment, nor rasterscanning illumination.
Imaging typically depends on contrast between image regions, be it differences in color
or in light intensity that highlight features of interest, and contrast can come from various
sources, both endogenous and exogenous. Endogenous sources in endoscopic systems include
hemoglobin absorption and inherently fluorescent molecules such as NADH and FAD, two
prominent markers of metabolism. Exogenous sources of contrast are more commonly added
prior to image acquisition, such as chromoendoscopy or fluorescent microendoscopy.
Chromoendoscopy depends on the colorimetric contrast provided by stains such as Lugol's
iodine or methylene blue [16]. These dyes are typically absorbed by the tissue in varying degrees
depending on properties such as increased or decreased cell cytoplasm or goblet cell presence
[16]. After these dyes are applied, they then require multiple rinses before imaging under white
light endoscopy [17]. A benefit of exogenous fluorescent dye based microendoscopy is the
increased signal to noise ratio, as the fluorescently stained regions are emphasized. Examples
include fluorescence microendoscopy using acridine dyes [7] and surface magnifying endoscopy
using the fluorescent emission of methylene blue [18]. Fluorescently stained regions will vary
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depending on the dye, for example acridine-derived dyes such as proflavine will preferentially
stain nucleic structures, whereas methylene blue will be preferentially absorbed by mucosal
tissue [5, 16]. Proflavine has been used as a topically delivered, exogenous contrast agent with
fluorescent microendoscopy systems due to its DNA intercalating nature. Therefore, proflavine
predominantly highlights cellular nuclei in cytology specimens [19], as well as squamous bulk
tissue such as oral and esophageal [5, 8]. Proflavine is an amphipathic dye comprised of a three
carbon ring structure, and capable of intercalation within the minor groove of the DNA helix
[20]. Broad acceptance of proflavine and its use in vivo in human subjects has been limited in the
United States as DNA-intercalating dyes are considered potentially hazardous and mutagenic
[21, 22]. Fluorescein, on the other hand, has a history of clinical use as an intravenous contrast
agent in retinal angiography, as it does not intercalate DNA and tends to diffuse between cells
rather than permeating them [23]. In addition, confocal microendoscopy modalities, such as
Mauna Kea, have successfully used intravenous (IV) delivery of fluorescein for gastrointestinal
imaging [24]. A limitation of fluorescein is its use as a contrast agent in squamous bulk tissue,
such as oral epithelium, where nuclei shape and homogeneity is a main indicator of dysplasia [8].
On the other hand, fluorescein has been shown to have a sensitivity of 88% for detection of highgrade intraepithelial neoplasia in Barrett’s esophagus, when using IV delivery in conjunction
with confocal microendoscopy [25]. When imaging with wide field modalities, such as the
microendoscopy system studied in this manuscript, we have shown that topical application of
fluorescein is sufficient to highlight crypt structures, while topical delivery via an auxiliary
endoscopy probe channel might minimize the amounts of systemic contrast agent [26].
Adequate contrast agents not only provide the clinician with in vivo qualitative insight,
but can be used to acquire and analyze digital images. Pathology studies of biopsies or sections
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typically depend on H&E slides qualitatively analyzed for pre-neoplastic markers such as nuclei
size, shape, distribution, as well as crypt structure [27]. Qualitative analysis of images acquired
with fluorescence microendoscopy by trained observers has been shown to be highly sensitive
and specific [15]. Intraobserver agreement was high, and provided positive results for subjective
review of microendoscopic images [15]. While there is a benefit to subjective and
complementary image analysis, introducing a new imaging modality into an intraoperative
setting necessitates a certain burden of training, namely additional training for the clinician.
Image acquisition can be combined with computer-based analysis and diagnostic algorithms to
provide complementary data to guide clinicians in their analysis of the tissue at the site of
interest [7, 28, 29]. Automated image analysis provides an objective, replicable output to lessen
the burden of training for clinicians. Our previous work has shown that the automated detection
sensitivity of crypt structures in images of proflavine-stained colorectal epithelium using a
custom algorithm ranges from 71 to 94% [30]. In addition, preliminary quantification of crypt
area and circularity suggest that crypt quantification may provide an unbiased metric for aiding
clinicians using fluorescence microendoscopy systems [27, 31].
In this study, we have evaluated the ability of topical proflavine and fluorescein to
provide contrast in colorectal epithelium using end-on fiber bundle microendoscopy imaging of
bulk ex vivo tissue. For qualitative comparison of topical staining, porcine and caprine bulk
colorectal tissue was stained with proflavine and fluorescein solutions and imaged. For
quantitative comparison, we have calculated the automated average crypt detection sensitivity of
our custom algorithm using porcine bulk tissue stained topically with proflavine and fluorescein.
In addition, ex vivo human colorectal tissue was imaged to quantitatively compare crypt area and
circularity in grossly normal and grossly dysplastic regions. These quantified results provided us
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with values in order to compare the viability of both these topical contrast agents for use in
conjunction with fluorescence microendoscopy systems. Our results present topical application
of fluorescein as a reasonable alternative to proflavine for fluorescence imaging of the colorectal
tract.
2. Materials and Methods
2.1 Fiber bundle microendoscopy system and topical contrast agents
The microendoscopy system has been previously described [7, 30], and consists of a
455nm LED (Philips, USA), a filter set (Chroma Tech, USA), monochrome camera (Flea 3, USB
3.0, Point Grey Research Inc., CA), a 10x objective (NA 0.25, Olympus, Japan), and a fiber
bundle image guide comprised of 50,000 fibers with 3.5µm center to center spacing (FIGH-501100N fiber, Myriad Fiber Imaging Tech, Inc., USA) with customized ends. The distal end has a
modified SMA connector with rounded edges, to reduce the risk of tissue tearing as well as
protect the fiber from chipping. Proflavine hemisulfate was prepared at a concentration of 0.01%
(w/v) in 1x phosphate buffered saline (PBS) [30]. Fluorescein salt solution was prepared at
0.05% (w/v) in 1x PBS. We used fluorescein sodium salt, with a reported solubility of 0.1%
(w/v) in water (F6377, Sigma-Aldrich), therefore our study investigated at and below this
concentration.
2.2 Image intensity as a measure of topical contrast agent concentration
Previous studies of clinical microendoscopy using topical proflavine have used a standard
concentration of 0.01% (w/v); we compared three concentrations of proflavine against
fluorescein salt solutions with equal weight-per-volumes. We sectioned 6 adjacent regions of
porcine colorectal tissue, and stained each section with one of the following contrast agents and
concentrations: 0.01% (w/v) proflavine, 0.05% (w/v) proflavine, 0.1% (w/v) proflavine, 0.01%
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(w/v) fluorescein, 0.05% (w/v) fluorescein, 0.1% (w/v) fluorescein, all solutions made with 1x
PBS. Ten images were acquired of each section, with identical camera settings; 50ms exposure
and 5dB gain. We qualitatively inspected them, as well as quantitatively compared them by
measuring the average image intensity. The average image intensity (N = 10 images) of each
solution was plotted; error bars denote standard error [Fig. 5]. Statistical values were obtained
from post-hoc testing of a one-way ANOVA using Tukey’s honestly significant difference
(HSD), with p-value <0.05 as the criterion for significant difference.
2.3 Animal tissue procurement
Microendoscopic images of freshly resected caprine colorectal tissue were acquired in
collaboration with the University of Arkansas Animal Science Abattoir, which provided tissue
from recently slaughtered animals at their facility. 12-inch distal colon specimens were resected
within an hour of slaughter, and imaged within an hour of resection. Siloam Spring Processing
provided porcine colorectal tissue from recently slaughtered animals at their facility. 12 to 24inch distal colon specimens were resected within an hour of slaughter, and refrigerated for
approximately an hour before imaging, and imaged within an hour of removal from refrigeration.
Specimens were obtained from two goats and two pigs for the quantitative study in this
manuscript. Colon sections were rinsed with water, longitudinally cut to expose the lumen, and
the lumen was rinsed with cold PBS. For each specimen, a single region of approximately 2
inches by 8 inches was sectioned for imaging.
2.4 Human tissue procurement
Microendoscopic images of freshly resected human colorectal tissue were acquired in
collaboration with the University of Arkansas for Medical Sciences, from consenting patients
under IRB protocol (#204651). Consenting patients, over the age of 18, with benign or
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carcinogenic disease, were accepted under this protocol. Colorectal tissue was resected and sent
to the pathology lab, where residents rinsed, longitudinally sectioned, and pinned the colorectal
tissue to a paraffin block. Three specimens (two cases of benign disease and one invasive
adenocarcinoma) were used for the data in this manuscript, with “normal” images acquired from
grossly appearing normal mucosa from each of the three specimens, as well as images of
neoplastic mucosa regions in the one specimen with invasive adenocarcinoma.
2.5 Microendoscopy image acquisition
The animal colorectal tissue was first longitudinally sectioned and then placed epithelium
side up on a 150mm Petri dish. Colon sections of each specimen, porcine and caprine, were
divided using a scalpel, with one section stained with proflavine and the adjacent section stained
with fluorescein. No specimen received both contrast agents on the same tissue area. Separate
sections of the specimen were used for multiphoton microscopy, though this separate section was
also divided into adjacent sections for individual staining. Microendoscopy images were
acquired immediately following topical application of proflavine (0.01% w/v in 1x PBS) or
fluorescein salt solution (0.05% (w/v) in 1x PBS) with a cotton swab to epithelial surface, with
occasional re-application of dye as needed. While endoscopic application of the dye would likely
be achieved through a spray nozzle port, gently rolling the cotton swab has been previously used
for ex vivo application without adverse effect for microendoscopic imaging [7, 8, 15]. Individual
images were acquired by manually placing the distal end of the fiber bundle in contact with the
epithelial surface of the tissue. Images of tissue stained with proflavine were acquired with
100ms exposure and 5dB gain and images of fluorescein were acquired with 50ms exposure and
5dB gain.
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Human colorectal tissue was pinned to a paraffin block, lumen side up, and for each
specimen, two regions of normal colon were chosen, as well as two regions of dysplastic colon.
Microendoscopy images were acquired immediately following topical application of fluorescein
salt solution (0.05% (w/v) in 1x PBS) with a cotton swab, with occasional reapplication of the
dye as needed. Individual images were acquired by manually placing the distal end of the fiber
bundle in contact with the epithelial surface. Image acquisition lasted approximately 30-40
minutes, with 50ms exposure and 5dB gain settings.
2.6 Multiphoton image acquisition for qualitative comparison
Two 1cm2 sections of caprine colorectal tissue were placed on individual glass slides,
topically stained with either proflavine (0.01% (w/v)) or fluorescein (0.05% (w/v)) solution, and
covered with No.1 coverslips, and immediately imaged using a MaiTai (SpectraPhysics)
Ti:Sapphire pulsed laser, coupled to a customized multiphoton microscope system with an
emission bandpass filter of 525nm center wavelength and 45nm bandwidth (Thorlabs). Images
from tissues stained with these two agents were acquired using 900nm two-photon excitation at
5mW power at the sample, and a 40x (0.8 NA) water immersion objective (Nikon). Images
comprised a 261µm by 261µm field-of-view, at 512 by 512 pixels.
2.7 Crypt detection and quantification algorithm and optimization of parameters
We have previously developed a custom image feature quantification algorithm (QFEA)
for automated crypt detection and quantification of crypt morphology in microendoscopic
images of proflavine-stained colorectal tissue [30]. This algorithm was designed to detect,
segment, and quantify area and circularity of crypt shapes in microendoscopic images, and
calculated automated crypt detection sensitivity at the crypt level by comparing if the algorithm
detected a crypt at the position that the trained observer visually detected a crypt [30]. We have
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optimized this algorithm for images of fluorescein-stained colorectal tissue, and compared the
crypt detection sensitivity of the algorithm for proflavine versus fluorescein-stained epithelium,
as described below. Prior to image quantification motion-blurred images were excluded from
quantification, then the signal-to-background ratio was calculated, which we have termed the
Quality Ratio (QR). We designed the QR metric to be a crypt-specific signal-to-background ratio
[30], as the pixel-by-pixel signal-to-background ratio can vary and be misleading when
calculated. The QR metric smooths individual pixel peaks and troughs, in order to calculate the
more general signal-to-background ratio of the crypts [7]. Pixel intensity line profiles were
extracted from the image in a grid like pattern, and the peak-to-trough ratios of the profiles were
averaged to calculate the image’s QR [Fig. 1(a)] [30]. Figure 1(a) shows an example of the line
profiles crossing through a crypt, with a representative example of a line profile through the
crypt shown to the right; these line profiles in actuality cover the entirety of the image. Images
were then contrast-enhanced for increased efficacy in image segmentation. The pixel intensities
are normalized to a range of 0 to 1, and contrast limit pairs have an upper and lower contrast
limit, for example [0.2 0.9]. These contrast limit pairs refer to how 1% of image pixels fall below
the lower contrast limit (0.2) and are mapped to a normalized signal value of 0, and 1% fall
above the upper contrast limit (0.9) and are mapped to a normalized signal value of 1. Contrastenhanced images were then binarized with a variable threshold automatically determined by
Otsu’s method [32], designed to minimize variance of values in the binary image. Figure 1(b)
shows the effect of different contrast limit pairs on binary images created for subsequent image
segmentation. The optimal contrast limit pairs will vary depending on the initial image intensity
and contrast, therefore need to be carefully selected for each topical contrast agent. In order to
determine the optimal contrast limit pairs for microendoscopy images of fluorescein-stained
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epithelium, 100 images of porcine tissue were subject to a range of contrast limit pairs, to
determine which pairs produced the highest automated crypt detection sensitivity values [30].
Automated crypt detection sensitivity was determined by comparing the sensitivity (true
positives divided by the sum of true positives and false negatives) of the algorithm to manual
crypt identification by a trained observer. Figure 1(c) shows the contrast limit pairs used to
optimize the crypt detection sensitivity; contrast limits were increased by 10% and ranged from
[0.1 0.2] to [0.8 0.9].

Figure 1. (a) Example of grid pattern on close-up of individual crypt (line profiles extracted
every 40 pixels), a single pixel intensity line profile plotted as an example, and peaks and trough
(red arrows) labelled. (b) Example of effect of changing the contrast limit pairs on conversion
into a binary image. (c) Table of contrast limit combinations tested for automated crypt detection
sensitivity. Contrast enhancement scales image intensity values (0 to 255) between 0 and 1. Both
upper and lower contrast limits were iteratively increased by 10% to cover a range from [0.1 0.2]
to [0.8 0.9]. Gray region depicts impractical contrast limit pairs. Scale bars are 100μm.
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3. Results
3.1 Qualitative image comparison of topical contrast agents
Both topical contrast agents provide similar qualitative crypt structure information in
microendoscopic images of superficial colon epithelium. Figure 2 shows a comparison of Figs.
2(a) and 2(b) fluorescein-stained, and Figs. 2(c) and 2(d) proflavine-stained, as well as Figs. 2(a)
and 2(c) porcine, and Figs. 2(b) and 2(d) caprine epithelial tissue. Pathology, the gold standard,
would use H&E staining to investigate the crypt shape, homogeneity, and nuclei shape and
distribution [27]. The selected fiber bundle was designed in favor of a larger field-of-view, which
inherently limits the resolution of individual nuclei. Using our system, neither proflavine nor
fluorescein staining permit a careful study of nuclei shape and distribution, but they do highlight
the shape and homogeneity of crypts. Both contrast agents delineate the inner crypts as dark,
mostly homogenous, circular regions, while also providing contrast to the interstitial regions.
While proflavine preferentially stains cell nuclei, leading to ring-like image features around the
dark crypts (arrows in Figs. 2(c) and 2(d)), fluorescein stains the interstitial spaces more
uniformly, while still providing contrast with the crypts (black arrows in Figs. 2(a) and 2(b)). In
our experiments, fluorescein had an increased likelihood to pool at the center of the shallower
caprine crypts [Fig. 2(e)], and appears as bright dot-like structures in the center of the crypts
(yellow arrow in b).
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Figure 2. Qualitative comparison between microendoscopic images of bulk colorectal porcine
and caprine tissue stained with proflavine and fluorescein. (a) and (b) Tissue stained with
fluorescein (0.04% (w/v) in PBS), imaged at 50ms exposure and 5dB gain. (c) and (d) Tissue
stained with proflavine (0.01% (w/v in PBS)), imaged at 100ms exposure and 5dB gain. (a) and
(c) Porcine tissue; (b) and (d) caprine tissue. All images have been equally contrast enhanced for
publishing; colorbar shows intensity values from 0 to 255. Scale bar is 250µm.
When imaged under a 40x 0.8NA objective for a 261µm by 261µm field of view, using
multiphoton microscopy, the subtle differences in staining are readily apparent. Fluorescein
stained bulk tissue [Fig. 3(a)] shows even staining of general intracellular material, as well as
greater pooling in the center of the crypts. As expected, since proflavine intercalates DNA [20],
proflavine-stained bulk tissue [Fig. 3(b)] preferentially stains individual nuclei. An example is
shown in the inset of Fig. 3(b), of an individual nucleus, where the red arrows point to the
nuclear membrane. Figure 4 shows the staining of both contrast agents at up to 100μm below the
epithelial surface, which is more than sufficient for an end-on fiber bundle system that gathers
data from the epithelial surface. This panel of depth sections additionally serves to exemplify

111

how topical application of these contrast agents might also be applicable for depth-sectioning
imaging modalities such as confocal microendoscopy.

Figure 3. Qualitative comparison between multiphoton images of bulk colorectal caprine tissue
stained with (a) fluorescein and (b) proflavine. (a) Tissue stained with fluorescein (0.04% (w/v)
in distilled water). Yellow arrow points to fluorescein pooling in the center of the crypt. (b)
Tissue stained with proflavine (0.01% (w/v in PBS)); white box inset shows a single stained cell,
with yellow arrow pointing to the nuclear membrane. Both images were taken at 100 cumulative
frames, 15fps, 20mW at sample, and have been equally enhanced for publication. Red scale bar
is 100µm.

Figure 4. Qualitative comparison of multiphoton images of bulk colorectal animal tissue stained
with fluorescein and proflavine at 20μm, 60μm, and 100μm below the epithelial surface. Caprine
tissue stained with fluorescein (0.04% (w/v) in distilled water). Porcine tissue stained with
proflavine (0.05% (w/v) in 1x PBS). All images were taken at 100 cumulative frames, 15fps,
20mW at sample, and have been enhanced for publication. Scale bar is 100µm.
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3.2 Image intensity as a measure of topical contrast agent
Qualitative comparison of matching weight-per-volume of proflavine and fluorescein
showed that while increasing proflavine concentration increased signal intensity, the signal of the
interstitial tissue was not as large in comparison to fluorescein. Quantitative results [Fig. 5]
supported this: average image intensity of fluorescein was significantly brighter than proflavine
at each individual concentration. There was little qualitative difference between fluorescein at
0.01% (w/v) and proflavine at 0.1% (w/v), which is supported by a quantitative lack of
significant difference between the average image intensity of these solutions.

Figure 5. Comparison of different concentrations of topical contrast agents. Three different
concentrations of each contrast agent, fluorescein and proflavine, were prepared at 0.01% (w/v),
0.05% (w/v), and 0.1% (w/v) in 1x PBS. Average image intensities (N = 10 images) of porcine
colorectal tissue were plotted; error bars denote standard error. Fluorescein was significantly
brighter than proflavine at each individual concentration, but fluorescein at 0.01% (w/v) was not
significantly different from proflavine at 0.1% (w/v); statistical values were obtained from posthoc testing of a one-way ANOVA using Tukey’s honestly significant difference (HSD), with pvalue.
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3.3 Optimization of contrast limit pairs for increased crypt detection sensitivity
As previously stated, a range of contrast limit pairs [Fig. 1(c)] were applied to 100
images of fluorescein-stained porcine tissue. The average sensitivity (defined as the number of
true positives divided by the sum of true positives and false negatives, as compared to manually
selected crypts) of each contrast limit is shown in Fig. 6 as heatmaps for 6(a) proflavine and 6(c)
fluorescein stained tissue. The internally numbered boxes were labelled for ease of correlation of
contrast pairs chosen to the Figs. 6(b) and 6(d) plots of average sensitivity at various
combinations of these chosen and labeled pairs; for example, in Fig. 6(a), value 1 stands for
contrast limit pair [0.5 0.9]. As described in our previous work [30], a combination of several
contrast limit pairs dramatically improves the average sensitivity of our crypt detection
algorithm. Based on the results of Fig. 6(b) we chose a combination of 5 contrast limit pairs for
optimal crypt detection sensitivity of images of proflavine-stained tissue, as the sensitivity
surpasses 80%. Based on the results of Fig. 6(d), we chose a combination of 3 contrast limit pairs
for optimal crypt detection sensitivity of images of fluorescein-stained tissue, as the sensitivity
surpasses 90% while reducing risk of overtraining.
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Figure 6. Optimization of crypt detection sensitivity by combination of contrast limit pairs for
porcine tissue stained with (a) and (b) proflavine (0.01% (w/v)) and (c) and (d) fluorescein
(0.04% (w/v) in PBS). (a) and (c) Heatmaps of the average percent sensitivity for each contrast
limit pair; colorbars are average percent sensitivity. As with Fig. 2, the x-axes display the upper
contrast limits, and the y-axes display the lower contrast limits. (b) and (d) Average test
sensitivity, after 10 iterations of fivefold cross-validation, for each contrast limit pair or
combination of contrast limit pairs. Maximum standard deviation of averages among all points
was <0.61%. Heatmaps (a) and (c) are internally numbered with the selection of the highest
sensitivity values per row, for clear correlation of numbered contrast limit pairs to the x-axis
combinations in plots (b) and (d).
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3.4 Quantitative image comparison of topical contrast agents
Our crypt quantification algorithm (QFEA) provided similar results for average crypt
detection sensitivity in images of proflavine and fluorescein stained porcine tissue. As shown in
Fig. 7, the QFEA was able to identify the majority of crypts for both topical contrast agents. One
hundred images of proflavine-stained porcine epithelium and 100 images of fluorescein-stained
porcine epithelium were quantified (QFEA) using contrast limit pairs selected using Fig. 6. As
described in Section 2.7, a global QR value (peak-to-trough ratio) was calculated for each image
as a metric of signal to background contrast, and the average QR of all images in a data set were
tabulated against the average crypt detection sensitivity of QFEA. In Fig. 8(a), the sensitivities
and positive predictive values (PPV) of images with a QR value equal to, or higher than, the
specified QR cutoff value (x-axis) were averaged for an aggregate average sensitivity at that QR
cutoff. The sensitivity was previously defined as true positives divided by the sum of true
positives and false negatives. PPV was defined as true positives divided by the sum of true
positives and false positives. The peak aggregate sensitivity for proflavine occurred at a QR
cutoff value of 1.08 [Fig. 8(a)]. QR cutoff values higher than 1.1 averaged less than five images
for average sensitivity and PPV calculation of proflavine-stained images, and are therefore not
reliable indicators due to undersampling. Average sensitivity of fluorescein-stained images
continued to increase slightly for QR values higher than 1.1, while PPV had a slight decline after
that point (not shown). It is of interest to note that images of proflavine were overall less
sensitive to automated crypt detection, but had a markedly greater PPV. Fluorescein had a PPV
that barely surpassed 70%, while proflavine had a PPV close to 90%. In contrast, fluorescein
demonstrated average sensitivities consistently above 90%, while proflavine sensitivity peaked at
almost 85% at a QR cutoff value of 1.06.
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Figure 7. Comparison of automated crypt detection between microendoscopy images of bulk
colorectal caprine tissue stained with (a) fluorescein and (b) proflavine. Yellow asterisks mark
the centroids determined with the QFEA. (a) Tissue stained with fluorescein (0.04% (w/v) in
distilled water). (b) Tissue stained with proflavine (0.01% (w/v in PBS)). Both images have been
equally enhanced for publishing. Scale bar is 200µm.

Figure 8. (a) Average sensitivity and positive predictive values (PPV) of the QFEA crypt
detection versus the QR cutoff value; aggregate performance plotted against QR was calculated
using images with QR values equal to or higher to the QR cutoff value labeled in the x-axis. PS:
Proflavine Sensitivity; PP: Proflavine PPV; FS: Fluorescein Sensitivity; FP: Fluorescein PPV.
(b) Percentage of images with QR values equal to or higher than the labeled QR cutoff value;
one hundred images per group. F: Fluorescein; P: Proflavine.
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3.5 Quantification of crypt area and circularity in preliminary clinical trial
Automated quantification of crypt area and circularity, using our quantification algorithm
(QFEA), was tabulated for regions with grossly normal, and adenocarcinoma diagnoses. 66
images, corresponding to approximately 25mm2 of epithelial surface, were acquired from grossly
normal regions (no dysplasia, no benign disease), and 76 images (~29mm2) from
adenocarcinoma regions. Figure 9 shows that there was significant difference between normal
(N.) and adenocarcinoma (A.) regions, with a p-value of 0.035 for area, but circularity was not
significantly different with a p-value of 0.13, using a Student t-test.

Figure 9. Quantitative comparison of crypt area and circularity. (a) Example of microendoscopic
images of normal and adenocarcinoma regions. Scale bar is 100μm. (b) Average crypt area for
normal and adenocarcinoma regions (N = 416 crypts, N = 603 crypts, respectively). P-value =
0.035. (c) Average crypt circularity for normal and adenocarcinoma regions (N = 416 crypts, N =
603 crypts, respectively). P-value = 0.13.

118

4. Discussion
Imaging of gastrointestinal epithelium via end-on fiber microendoscopy has been
explored using DNA intercalating dyes, which so far have been used as investigational drugs in
the United States [5, 15, 30]. A fluorescence alternative would be dyes already in clinical use,
such as sodium fluorescein solution [33]. Our qualitative comparison of microendoscopy images
of bulk colorectal tissue stained with fluorescein versus proflavine demonstrated that while the
subcellular staining patterns differ [Fig. 3], fluorescein is able to provide similar information of
crypt morphology to the previously established proflavine [Fig. 2]. An additional benefit of
fluorescein as a contrast agent, in comparison to proflavine, includes reduced exposure time for
images. Images of fluorescein-stained tissue were initially acquired at 100ms, for identical
integration time of proflavine-stained tissue, but the images were over-saturated and we lowered
the integration time until the images were of equal qualitative quality to proflavine. This resulted
in fluorescein-acquisition at 50ms and proflavine-acquisition at 100ms. Reducing the required
integration time has the benefit of reducing the number of motion-blurred images. Reduced
exposure time and reduced motion-blur is an important advantage for manual or in vivo
acquisition, allowing for the flexibility of manually holding the probe yet not requiring the
clinician to have steady hands. While clamping the probe during image acquisition would have
eliminated motion from unstable handheld placement, we chose to retain the potential of motionblurring in order to mimic in vivo imaging, where patient breathing or movement could
contribute to motion-blur. Quantitatively, the results of automated crypt detection demonstrated a
sharp increase in crypt detection sensitivity using less combinations of contrast-limit pairs; while
proflavine images required a combination of five contrast limit pairs to achieve greater than 80%
average sensitivity, fluorescein images required a combination of only three contrast limit pairs
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to achieve an average sensitivity greater than 90% [Fig. 6]. A reduced number of contrast limit
pairs is computationally time efficient, as well as reducing the risk of overtraining the algorithm.
In addition to contrast limit pair combinations, the average sensitivity of the crypt detection
algorithm is greater for the fluorescein data set. Even excluding images with low signal-tobackground contrast (at a QR cutoff value of 1.06, Fig. 8(a)), the average crypt detection
sensitivity of the proflavine data set never reached 90%, whereas the fluorescein data set average
sensitivity was consistently greater than 90%. Despite this, the fluorescein data set has a
consistently lower positive predictive value (PPV) [Fig. 8(a)]. Heatmaps of the PPV (data not
shown) showed similar results to the sensitivity heatmaps, sharing the top two contrast limit pairs
as resulting in the highest sensitivity and PPV values. This suggests that quantitative analysis of
fluorescein images is more sensitive in the detection of crypts, while not as adept as a diagnostic
tool due to a higher number of false positives, thought this requires additional investigation into
alternative reasons for this imbalance. Quantitative crypt detection results suggesting a lower
PPV are not necessarily a critical limitation for clinical translation of a microendoscopic system.
Given the length and size of the colorectal tract, there is minor risk in extracting multiple
biopsies and therefore the surgical recommendations is to biopsy two to four regions each 10cm,
with additional sampling of suspicious regions [34]. A highly sensitive, if not specific, tool
would be useful in improving biopsy targeting of abnormal regions. While microendoscopic
systems have achieved high sensitivity and specificity rates [15], they have not yet proven
capable of replacing the gold standard of pathological staging of biopsies, therefore
microendoscopy remains most useful in complementing existing endoscopy procedures. Our
preliminary clinical results show that the automated algorithm measures a significant difference
between crypt areas of normal and dysplastic regions, and additional work could increase the
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accuracy and breadth of quantifiable image features. One drawback of automated quantification,
though, is that there is usually an increased regulatory burden when a system uses computer
based diagnosis, which is not an attractive prospect for vendors.
Fluorescein is also more relevant as a clinical contrast agent, compared to DNA
intercalating dyes, since it is already clinically used for intravenous injection and has
demonstrated to pose limited risk to patient health. A drawback that should be considered is that
intravenous fluorescein has a risk of anaphylaxis, with death from complications after
intravenous injection during angiography procedures estimated at 1 in 220,000 patients [35].
Analysis of intrathecal administration of fluorescein in Europe and the United States showed that
when a fluorescein dose of 1mL per 10kg of body weight of 5% (w/v) was used (total 50mg),
side effects were minor and transient, with additional complications reported for higher doses
(total 100-700mg) [35]. The side-effects of intravenous injection for confocal endomicroscopy
have been similarly reported as minor for doses of up to 5mL of 10% (w/v) fluorescein, and
while participants in their study experienced no severe reactions, the authors caution that
anaphylaxis is rare but should be “anticipated and prepared for as for any drug [24]”. It is unclear
if a topical application of the stain could possibly have reactions of equal or lesser severity.
Alternatively, topical application of fluorescein required only the lower recorded concentrations
of fluorescein, and could potentially pose little risk to the patient in small topical doses. Despite
some limitations, we have described in this manuscript how topical application of fluorescein
holds promise as a potential contrast agent alternative to proflavine for glandular tissue,
specifically colon, since the crypt structures visible using proflavine are also visible when
imaging with fluorescein. Using a 1mm fiber bundle, images acquired with both proflavine and
fluorescein contrast offer similar image features for quantification, such as crypt area and
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circularity. There was over 90% crypt detection sensitivity of porcine tissue, as well as statistical
significance in our preliminary clinical study using topical application of fluorescein solution,
between grossly normal and grossly dysplastic regions of colorectal tissue.
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Chapter V: Differences in colonic crypt morphology of spontaneous and colitis-associated
murine models via second harmonic generation imaging to quantify colon cancer
development [1]
1. Background
Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the
gastrointestinal tract and is manifested clinically as either ulcerative colitis (UC) or Crohn’s
disease [2]. While there is currently no specific histological feature that is used to definitively
distinguish between UC and Crohn’s disease, an important distinction is the distribution pattern
of the inflammation. UC is characterized by severe inflammation beginning at the rectum and
continuing throughout the colon; Crohn’s disease is characterized by lesions over Peyer’s
patches, and non-continuous regions of inflammation that span the entire depth of the intestinal
wall [3-5].
Patients with UC exhibit an increased risk for colorectal cancer (CRC); approximately
29% of UC patients develop CRC within 10 years of diagnosis, while 2.9% with Crohn’s disease
develop CRC after 10 years of disease [6-9]. There are different types of lesions that may be
detected in a UC patient during colonoscopy: two types associated with intraepithelial neoplasia
are a dysplasia-associated lesion/mass (DALM) and an adenoma-like mass (ALM) [10, 11]. Flat
or raised lesions without sharp contrast (delineation) against non-dysplastic epithelium are
typically classified as DALMs, and are frequently associated with malignancy [11]. ALMs have
features similar to sporadic adenomas that are observed in non-IBD patients [12]. Preliminary
studies have suggested that standard polypectomy, a complete endoscopic resection of the ALM
mass, followed by endoscopic surveillance is highly successful in patients with an ALM and
could spare the patient a colectomy, since of the 34 patients in one study only one patient
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developed an adenocarcinoma following the initial polypectomy [10-12]. Unfortunately, in 5080% of DALM cases the lesions are not visible during standard endoscopy [11, 13].
Several modalities of endoscopic imaging have emerged to improve detection of flat or
discolored lesions [14]. Among them, multiphoton microendoscopy uses nonlinear optical
processes to yield label-free high-resolution image data and rapid 3-dimensional image
acquisition up to several hundred microns in depth without the need for tissue resection and
subsequent fixation [15]. These systems have recently overcome a number of specific technical
challenges, including obtaining uniform scans, low sensitivity, durability and reliability of the
scanner, and miniaturization of the distal scan mechanism [16, 17]. Miniaturization of
multiphoton laser microscopy systems greatly enhances the clinical translatability of this
modality, leading towards in vivo imaging applications in gastrointestinal epithelial tissues [1820]. A form of multiphoton imaging, second harmonic generation (SHG) is a nonlinear optical
process whereby non-centrosymmetric crystalline structures (such as collagen) interact with two
low energy photons nearly simultaneously, resulting in the generation of a new photon at twice
the energy (or half the wavelength of the incident photons). Multiphoton endoscopic systems
capable of SHG imaging show great potential in improving clinical decision-making for patients
with IBD. In the colon, collagen structures can be used to quantify changes in the threedimensional crypt microstructure in the setting of IBD and associated dysplastic transformation.
A systematic, quantitative model of these optical biomarkers of dysplasia progression could
guide clinical translation of SHG imaging approaches for IBD patients.
Our study was designed to further develop this biomarker model via SHG imaging and
quantification of morphological changes that occur in the crypt structures of murine models of
spontaneous and colitis-associated colorectal tumors. A series of azoxymethane (AOM)
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injections is used as a murine model for spontaneous (ALM-like) tumor progression as it induces
polypoid growth in the distal colon, similar to human CRC [21]. AOM injections followed by
subsequent administration of dextran sodium sulfate salt (DSS) is considered to have long-term
effects that produce cancerous flat lesions or dysplasia-associated lesion or mass (DALM-like)
similar to those observed in humans [22]. We also acquired SHG images of epithelial tissue over
discrete timepoints to investigate if temporal changes in crypt microstructure could be detected
and quantified at varying stages of tumor progression. Key SHG image features could serve as
optical biomarkers; a translatable measure towards detection of lesions and distinguishing ALM
and DALM type lesions endoscopically in patients with known IBD.
2. Methods
Murine models and colorectal tissue procurement
Two murine models were used for this study: a spontaneous colorectal carcinoma model
and a colitis-induced colorectal carcinoma model [21]. Thirty-one A/J mice (The Jackson
Laboratory, ME, USA) were used in accordance with the University of Arkansas Institutional
Animal Care and Use Committee-approved protocol #18093. Mice were received at 9 weeks of
age and allowed to acclimate for one week in a temperature and light controlled facility; mice
were maintained on an 12 hour day-night cycle, with a bedding mixture of approximately 75%
aspen chip bedding (7090A, Envigo, USA) and 25% paper product bedding (7099, Envigo,
USA). All procedures were conducted in the light phase. Food (Tekland 8640, Envigo, USA) and
water were provided ad libitum (Fig. 1). Mice were anesthetized using 1.5% isoflurane
(IsoThesia, Henry Schein Animal Health, OH, USA) and oxygen (Compressed USP Oxygen,
Airgas, PA, USA) from a precision vaporizer (911103, VetEquip, CA, USA), then placed on a
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heating pad (TP700, Stryker Medical, MI, USA) with a nosecone for constant supply of 1.5%
isoflurane.
The spontaneous colorectal carcinoma model (referred to as the AOM model), consisted
of a series of six weekly subcutaneous injections of AOM (A5486, Sigma-Aldrich, Inc., MO,
USA) diluted in sterile saline, at a dose of 10 mg per kg body weight [21]. Control mice
underwent a series of six weekly subcutaneous injections of saline (injection site over the
shoulders). AOM and Control cohorts acclimated and were injected in parallel. The colitisinduced colorectal carcinoma model (referred to as the AOM-DSS model) consisted of a single
AOM injection (at 10 mg/kg body weight, subcutaneous administration), followed by several
courses of drinking water supplemented with DSS (36,000-50,000 molecular weight, SKU
0216011080, MP Biomedicals, OH, USA) at a concentration of 1.5% (w/v) (Fig. 1) [21]. AOMDSS cohorts acclimated and were injected a few months after the AOM and Control cohorts.
Subcutaneous AOM injections were administered with 28 gauge syringe needles (BD329410,
VWR, PA, USA) in volumes of less than 200 μL. For the AOM-DSS model, beginning on the
day of the AOM injection, mice were provided free access to DSS solution for seven days [21].
On Day 8, the mice were provided untreated drinking water ad libitum for 14 days, and then the
DSS-solution and untreated water cycle was repeated at Day 22 and Day 53 (Fig. 1) [21].
Post treatment, mice were provided food and water ad libitum and were weighed and inspected
daily until two weeks after concluding AOM/DSS treatment, after which they were inspected
daily and weighed weekly. Mice were euthanized at early (20-23 weeks) or late (24-28 weeks)
time points, representative of early or late-stage carcinoma progression (Fig. 1). Mice within
each cohort were randomly selected for euthanizing at either early or late timepoints. Figure 1

129

notes the number of mice per cohort: Control n = 9, AOM early n = 6, AOM late n = 3, AOMDSS early n = 4, AOM-DSS late n = 9.

Figure 1. Timeline of murine models. Day 1 is the first azoxymethane injection, for mice at 10
weeks of age. Number of mice euthanized per time point and cohort labelled by n values.
AOM-injected mice develop lesions and small polyps at approximately 20 weeks, with
tumors progressing in size over the subsequent weeks; mice began to show signs of rectal
bleeding past 28 weeks and were therefore euthanized [21]. Mice were euthanized via
anesthetized cervical dislocation. Murine colons were resected within 15 minutes of euthanasia,
and a 1 cm section of distal colon was longitudinally sectioned and placed on a coverslip for
imaging. An adjacent section of tissue was fixed in formalin and paraffin-embedded for
reference H&E staining.
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Multiphoton microscopy imaging system
The microscopy system comprises a titanium-sapphire ultrafast femtosecond pulsed laser
source (Mai Tai eHP, Spectra-Physics, CA, USA), and galvo-resonant scan head scanners which
acquires a fixed 15 frames per second (MPM-SCAN64J, Thorlabs, USA). The laser power was
controlled via a quarter-wave plate and a polarizing beam splitter, to reduce the incoming
excitation power at the sample to the range of tens to hundreds of milliwatts. The light was then
circularly polarized, to reduce orientation bias of SHG in collagen, by use of a half-wave plate
and a second polarizing beam splitter. Circular polarization was determined by measuring
intensity of orthogonal collagen fibers at multiple regions, and selecting the optimal positioning
of the half-wave plate for reduction of intensity variation at different orientations. Following the
scanning optics, the illumination laser beam (at 800nm wavelength) passed through the back
aperture of a 20x water immersion objective (0.85 NA, Nikon, NY, USA), prior to illuminating
the sample, which was placed above the objective on an inverted microscopy stage.
Backscattered SHG signal was collected via the objected and traveled through a 635nm long pass
dichroic beamsplitter (Di02-R635, Semrock, NY, USA), a 447/60nm filter set (447/60nm 25mm
dia. filter, Semrock, NY, USA), a 400nm/40nm filter set (400/40nm 25mm dia. filter, Semrock,
NY, USA), and photomultiplier tube (H7422 PASO, Hamamatsu, Japan). The entire optical
system resides inside an enclosure to reduce ambient light.
Second harmonic generation image acquisition
Freshly resected tissue was placed epithelium-down on a 24x40 mm No. 1 coverslip, then
imaged using our non-linear optical microscopy imaging system described above. Total image
acquisition time was approximately 1.5 seconds, with total optical power at the sample limited to
prevent photo-damage. Individual images were acquired at 512 x 512 pixels at 14-bit depth,
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yielding a 522 μm x 522 μm (~0.27 mm2) field of view, at approximately 20 μm from the
epithelial surface. Image stacks were acquired at consecutive depths from the epithelial surface,
in 20 μm steps, from 20 μm to 100 μm below the epithelial surface (Fig. 2).

Figure 2. Comparison of histology and SHG images of Control murine colonic epithelium. (a)
H&E stained transverse section of Control murine colonic epithelium; scale bar is 100 μm.
Example of an SHG stack was shown, with images of depths at 20 μm, 40 μm, 60 μm, 80 μm,
and 100 μm (epithelial layer), and 160 μm and 180 μm (muscularis layer), from top to bottom.
Scale bar is 100 μm.
Optimization of automated crypt detection sensitivity
In previous work, we developed an algorithm for determining optimal parameters for
binarizing grayscale images of colon epithelium [23, 24]. The image intensities were re-scaled
between 0 and 1, and the thresholds for binarizing were optimized for maximizing the ability of
the algorithm to segment crypts can vary depending on the strength of the SHG signal in the
tissue (details are included in Supplemental Information). The selected optimal parameters for
the SHG image data set was calculated to have a 67% crypt detection sensitivity (CDS), when
compared to manual selection of crypt locations.
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Quantification of crypt image segmentation
Following the optimization of the threshold combinations for the algorithm’s % CDS, the
optimized algorithm was applied to the image set and the images were converted into a binary
image, where white objects were defined as the detected crypt structures [23, 24]. Figure 3
summarizes the image features that were quantified, as well provides a visual representation of
the calculation. Details of the image segmentation algorithm are included in Supplemental
Information. Early stages of CRC typically include regions of abnormal morphology, for
example, aberrant crypt foci (ACF) which are enlarged or non-tubular (branching) crypts, and/or
multiple layers of cells lining a crypt [25, 26]. We chose to measure various crypt morphology
image features related to changes viewed during histopathology, including crypt area, circularity,
and distribution. The mean and standard deviation (referred to as variance in the results) of each
image feature within each image were compared via a nested one-way ANOVA. The standard
deviation of the image features within each image was calculated in order to measure the
heterogeneity of the crypt structures; for example, tumor-adjacent regions tend to have both
abnormally large and abnormally small crypt structures, which could produce a mean in a normal
range, but the standard deviation of crypt areas within an image would retain the heterogeneous
nature.
The results of the quantification of image features were then compared across cohorts:
AOM early time point, AOM late time point, AOM-DSS early time point, AOM-DSS late time
point, and Control. Nested one-way ANOVA with Tukey’s post-test was used to determine
statistically significant differences between the cohorts (JMP Pro 13).
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Figure 3. Summary of quantitative image features. Each image feature is described with an
equation and a visual representation of the calculation using an SHG image of normal
epithelium; scale bar is 100 μm. For eccentricity, a represents half the length of the major axis,
and b represents half the length of the minor axis. For nearest neighbor, (xc,yc) represents the
centroid coordinate and (xa,ya) represent the centroid coordinates of adjacent crypts; the arrows
represent the distance to adjacent crypts, the red arrow represents the distance selected as the
nearest neighbor. For the centroid distance functions (CDF), (xc,yc) represents the centroid
coordinate and (xb,yb) represent the boundary pixel coordinates. The average CDF was calculated
by averaging all the distances to the boundary pixels (red arrows); the minimum CDF was
calculated by selecting the distance to the closest boundary pixel (red arrow); the maximum CDF
was calculated by selecting the distance to the furthest boundary pixel (red arrow).
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Depth section image analysis
Each sample was imaged from 20 μm to 100 μm below the epithelial surface in 20 μm
increments (Fig. 2); depth stacks were acquired from each sample at one to three locations on the
tissue section. Regions in normal epithelium were selected randomly. Regions in AOM and
AOM-DSS epithelium were selected adjacent to tumors; tumors were characterized as epithelial
regions with SHG signal but no discernable crypt structures. These depth section images were
then analyzed with the algorithm to quantify the previously described image features. The results
were then compared across depths, as well as across AOM and AOM-DSS cohorts. Nested twoway ANOVA with Tukey’s post-test was used to determine statistically significant differences
between the cohorts (JMP Pro 13).
3. Results
Qualitative comparison of second harmonic generation images
Figure 4 shows examples of histology and SHG of both AOM and AOM-DSS murine
models. Normal crypt structures tends to be uniform in size and general shape across the field of
view, with crypt shape being tubular in transverse view (Fig. 4a) and roughly circular in en face
view (Fig. 4b, h, i). Collagen distribution appears relatively even throughout the field of view
(Fig. 4b, i). Crypt structures directly adjacent to tumor regions, or in regions of early dysplasia,
tend to vary in size across a field of view, with one or more crypts being enlarged (Fig. 4c, d, k),
and crypts often being oblong and/or having serrated edges in en face view (Fig. 4e). SHG
images of grossly visible tumors do not show any discernable crypt structures (Fig. 4f, k).
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Figure 4. Examples of traditional H&E histology and SHG images of AOM and AOM-DSS
murine tissue. (a,b,h,i) normal epithelium, (c,d,j,k) epithelium adjacent to a tumor, and (e,f)
tumor region; all scale bars are 100 μm. (g) Image of a longitudinally sectioned AOM murine
colon, exposing the epithelium and a grossly visible tumor; scale bar is 0.5 cm. (d) Red arrow
points to an abnormally large crypt; yellow arrow points to an example of a serrated edge. (k)
green arrow points to an enlarged crypt in the tumor-adjacent region; blue arrow point toward
tumor edge. All images were manually contrast enhanced for display.
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Increased mean distance between crypts in AOM vs. AOM-DSS cohorts
Nearest neighbor and crypt circularity image features showed significant differences
between spontaneous CRC tumor and colitis-associated tumor models. Figure 5 shows
statistically significant comparisons of the cohorts for the mean of the nearest neighbor (a), and
the standard deviation (variance) of the nearest neighbor (b) and circularity (c). Results for all
image features, including non-statistically significant, are included as Supplemental Figures.
There was statistical significance when comparing AOM and AOM-DSS cohorts using nearest
neighbor quantification (Fig. 5 a, b). Mean nearest neighbor was greater for AOM late and
AOM-DSS early cohorts as compared to the Control (Fig. 5 a). AOM late cohort mean nearest
neighbor was also greater than the AOM-DSS early cohort (Fig. 5 a). When comparing the
variance of nearest neighbor, once again AOM late and AOM-DSS early cohorts had greater
values than the Control (Fig. 5 b). The variance of the AOM late group was also significantly
greater than the AOM-DSS late group (Fig. 5 b). Measuring the variance of circularity of the
cohorts showed a difference between the AOM early cohort and the Control (Fig. 5 c).
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Figure 5. Mean values of nearest neighbor, and of the standard deviation of crypt nearest
neighbor and circularity. Cohort n values (images): AOM early n=48, AOM late n=23, AOMDSS early n=45, AOM-DSS late n=24, Control n=55. Error bars are standard error; significance
was calculated via a nested one-way ANOVA with Tukey’s HSD post-test. Significance was
noted (*) for p values <0.05 and (**) for p values <0.01.
Differences in circularity and mean distance between crypts in tumor-bearing vs. Control
cohorts at varying acquisition depths
As previously stated, images were taken at increasing depths: 20, 40, 60, 80, and 100 μm
into the epithelial layer. We applied the image feature quantification algorithm to each depth, per
treatment cohort. There were 43 image stacks (5 images in a stack, 20-100 μm) in total between
all 5 cohorts. Mean and standard deviation of image features was compared across cohorts, at
specific depths of acquisition (Fig. 6). As previously described, the mean and standard deviation
(variance) within an image of each image feature was compared via a nested one-way ANOVA.
Results for all image features with at least one statistically significant difference between two
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cohorts are included as Supplemental Figures. There were significant differences between the
Control cohort and AOM cohorts, and Control and AOM-DSS cohorts, for mean nearest
neighbor at depth of specifically 40 μm, as well as standard deviation of circularity at a depth of
specifically 60 μm, when comparing image stacks. No image feature showed significant
differences between the AOM early and AOM late cohorts, nor the AOM early and AOM-DSS
early cohorts (Fig. 6 a-c).
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Figure 6. (a, b) Mean and standard deviation of crypt nearest neighbors at 40 μm depth. (c)
Standard deviation of crypt circularities at 60 μm depth. (d) Standard deviation of crypt
circularity at a range of imaging depths in microns, for AOM late cohort. Cohort n values
(stacks): AOM early n=8, AOM late n=9, AOM-DSS early n=5, AOM-DSS late n=12, Control
n=9. Significance was calculated via two-way ANOVA with Tukey’s post-test. Error bars are
standard error. Significance was noted (*) for p values <0.05 and (**) for p values <0.01.
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Decreased crypt circularity at increased acquisition depth for AOM late cohort
As previously stated, images were taken at increasing depths: 20, 40, 60, 80, and 100 μm
into the epithelial layer. Mean and standard deviation of image features was compared across
depth of acquisition within each cohort (Fig. 6 d) via a nested one-way ANOVA. Results for all
image features with at least one statistically significant difference between two cohorts are
included as Supplemental Figures. There was no significance for mean of image features within
cohorts; there was significance within the AOM late cohort for standard deviation of circularity
(Fig. 6 d). There were differences between 100 μm and the more superficial 20 and 40 μm, for
standard deviation of circularity of the AOM late cohort.
4. Discussion
Various modalities of endoscopic imaging have emerged with the goal of improving early
detection of flat or discolored lesions, such as chromoendoscopy, narrow band imaging, and laser
microendoscopy [14, 27]. Chromoendoscopy consists of spraying a colorimetric stain, such as
indigo carmine, to provide contrast during colonoscopy [28]. Narrow band imaging has been
described as label-free chromoendoscopy, as the optical filters only allow imaging small range of
wavelengths, which enhance contrast in blood vessels and capillary patterns without the need for
a contrast agent [27, 28]. While chromoendoscopy and narrow band imaging have shown
promise for improving detection of dysplastic/neoplastic lesions, they are not able to distinguish
between the similar structures of ALM and DALM lesions [14]. Laser confocal microendoscopy
features high spatial resolution - able to resolve cellular and subcellular structures - providing
more detailed imaging features that relate more closely to histopathological features [11]. The
Cellvizio® confocal laser microendoscopy system showed potential in differentiating between
DALM lesions and adjacent normal colorectal epithelial crypt structure in a preliminary clinical
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trial [29]. Inserting the Cellvizio® endoscopic probe into an existing working channel during
colonoscopy showed that DALM regions had enlarged crypts, increased irregularly in the
distribution of crypts, increased space between crypts, as well as crypt destruction or fusion [29].
In contrast to confocal laser microendoscopy, multiphoton microendoscopy has additional
benefits, including the ability to acquire label-free images of structural/morphological
information (via SHG imaging) as well as insight into metabolic information (via
autofluorescence of intrinsic biomolecules, such as nicotinamide adenine dinucleotide and flavin
adenine dinucleotide, among others) up to several hundred microns in depth [30-33].
SHG imaging, as shown in this manuscript, is well-suited for characterization of collagen
structures, especially collagen type I which makes up much of extracellular matrix and
connective tissues [30, 34]. SHG imaging of colorectal epithelium highlights crypt shape, as the
collagen fibers provide structure surrounding the cellular arrangement without the need for any
exogenous contrast agent [35]. We have described our analysis of colorectal epithelial
microstructure from SHG images of freshly resected murine colons using automated
quantification of morphological image features. These results - a comparison of quantified
features of crypt morphology (especially nearest neighbor and circularity) - demonstrated the
ability of our quantitative image feature algorithms to detect differences between spontaneous
(AOM model) and colitis-associated (AOM-DSS model) murine colorectal tissue specimens.
Limitations of SHG imaging include the ability to acquire structural but not cellular information,
as well as the need for clinician/investigator judgement to recognize some additional parameters
during imaging, such as the presence of tumors which are not detected nor measured by the
automated quantification algorithm.
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Future work in this area will include murine models of familial adenomatous polyposis,
and other hereditary models, to more thoroughly investigate the morphological features of the
most common types of CRC. A common murine model of familial adenomatous polyposis featuring a deletion of the APC gene - develop spontaneous adenomas in the colon, although
these lesions may not fully exhibit the physiological features of the disease as seen in humans
[36]. Despite some limitations, the APC/min mouse model and other models will be included in
future SHG imaging studies in order to expand the scope of the current work, which is limited to
spontaneous and colitis-associated tumor development.
The image biomarkers in this study relate to crypt morphology features that are
analogous to conventional endoscopic biopsy and histopathology: crypt shape, size and spatial
distribution. Statistically significant differences between spontaneous tumor (AOM) and colitisassociated tumor (AOM-DSS) cohorts indicate that different models of tumor progression can
potentially be quantified via SHG imaging, possibly distinguishing between early and late tumor
progression. However, none of the image features - which are based solely on collagen-derived
SHG signal - in this study showed statistical differences within tumor-bearing cohorts, or
between early and late time points of AOM cohorts. It is possible that combining SHG data with
autofluorescence imaging data could be a promising technique for acquiring intraoperative
complementary data in order to improve endoscopic differentiation between ALM and DALM
lesions in patients with UC, but this would require additional study.
These results provide a quantitative model of the morphological changes that crypts
undergo during dysplastic transformation, and can serve to guide future translational
investigation and clinical studies in patients with IBD, with the long-term goal of reducing
morbidity associated with prophylactic colectomy.
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Conclusion
A number of factors contribute to dysplastic transformation in colon epithelium, and it is
important to fully understand disease progression in order to improve techniques and tools for
screening, diagnosis, and treatment. While studies of collagen fiber structure using optical
imaging in cancers such as cervical have been conducted [18], investigation of collagen
structures in murine CRC studies has been understudied [37]. Multiphoton endoscopic imaging
has shown to be a feasible technology for clinical translation due to its miniaturization and labelfree image acquisition. The introduction of image analysis algorithms into computer-aided
diagnostic methods yield complementary data to conventional endoscopic procedures, which
could lead to improved clinical decision-making for patients with known IBD. The methods
described here provide insight into the ability of SHG imaging to yield relevant data about the
crypt microstructure in colorectal epithelium, specifically the potential to distinguish between
ALM and DALM murine models using quantification of crypt shape and distribution, informing
future design of translational multiphoton imaging systems and protocols.
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Chapter VI: Conclusion
Optical imaging is an active field of investigation for biomedical engineers providing a
variety of applications, from low-cost point-of-care systems to highly sensitive multiphoton
imaging systems. Oral and colon cancer – epithelial cancers – have unique cellular morphologies
that can be analyzed with optical imaging, ranging from histopathological imaging to
investigative imaging systems.
1. Proflavine as a contrast agent for oral cell cytology
Oral cancer, specifically oral squamous cell carcinoma (OSCC), is the sixth most
common cancer worldwide and most prevalent in low-resource countries and locations, such as
rural Bangladesh, India, and Sri Lanka [1-4]. The prevalence of chewing betel and other
carcinogens puts people living in these locations at high-risk of developing OSCC, contributing
up to 25% of all new cancer cases in males [4]. There have been a variety of investigations
designed to reach these populations, but they rely heavily on volunteers and visual inspection [2,
5, 6]. Oral screening procedures designed to collect and analyze exfoliated cells have been
investigated since 1963, but had poor sensitivity and specificity until the development of the
cytobrush (designed for cervical smears) in the 1980s [7-10]. The OralCDx is an oral brush and
computer-aided laboratory analysis based in the United States, which allows clinicians to collect
cells from the entirety of the oral epithelium (including the basal layer) and the brush is sent to
the laboratory for processing [11, 12]. The analysis is conducted on H&E stained cells using a
specialized image processing system, and a cytopathologist makes the final diagnosis, and the
OralCDx has shown over 90% specificity and sensitivity [11, 12]. A similar system could be a
viable option for screening of oral lesions in high-risk populations.
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We acquired images using proflavine and fluorescence imaging, and discernable
morphological structures included clearly defined nuclei, Golgi zones, and visible cellular
membranes. The use of proflavine in oral cell cytology and quantification of the image features
had not been previously investigated. From a morphological standpoint, OSCC stained with
proflavine was distinguishable due to its size, and much larger nuclear-to-cytoplasm ratio.
Quantitative analysis of this nuclear-to-cytoplasm ratio showed that nuclear-to-cytoplasm ratio
was significantly larger in OSCC cells than normal cells, with OSCC displaying an average ratio
of approximately 0.8 and normal cells an average ratio of less than 0.1. Our results showed that
proflavine was a suitable alternative for fluorescence imaging of OSCC cells; proflavine
highlighted similar morphological features to clinical cytological stains; and quantification of
nuclear-to-cytoplasmic ratios showed significantly larger ratios for OSCC [13].
Limitations of many of the OSCC screening studies in low-resource locations has been
compliance in travelling to a clinic (e.g. ~50% in the Indian sub-continent), despite the offer of
reimbursement for time and travel [6]. In addition, exfoliation of oral cells has shown mixed
results, and is often considered most viable when the oral brushes can collect cells deep enough
into the epithelial layer to collect cells from the basal layer [14], however this can be painful.
Additionally, a limitation for optical imaging is the compromise between resolution of
morphological structure and field-of-view; imaging setups can usually either image subcellular
level detail or image a large number of cells in a short amount of time, but not both. In order to
ensure that OSCC cells are not undercounted due to reduced field-of-view, it would be important
for any clinical system to test the number of basal and OSCC cells that can be acquired and
imaged through oral exfoliation, in a clinical study.
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Proflavine could be considered in future point-of-care optical device design with the
incorporation of computer-aided image segmentation in order to measure image features, for
example nuclear-to-cytoplasm ratio as we have showed, to create systems for rapid analysis of
exfoliated oral cells. A recent study showed that 74% of subjects experienced no or mild
discomfort due to the Orcellex cytobrush and produced on average 55,500 cells per slide,
including cells from all layers of the epithelium, such as basal (deep), spinosal (middle) and
superficial cells [15]. This shows that there is promise for cytobrush oral cell acquisition with
minimal pain, high cell count, and high cell diversity. A one-step proflavine staining method
could be used to qualitatively inspect cells in these systems via a similar approach to the
aforementioned Orcellex, OralCDx, or in studies with additional morphological parameters such
as a study by Remmerbach et. al. [16]. They proposed another technique, where the combination
of cellular morphology (including nuclear-to-cytoplasm ratio) and DNA-aneuploidy (extra or
missing chromosomes) had increased sensitivity specificity compared to the OralCDx [16]. This
study used both Papanicolau and Feulgen staining followed by automated segmentation of
individual nuclei [16]. Therefore, future studies could consider proflavine as an alternative
contrast agent for the analysis of a combination of cellular and nucleic morphology.
Automated quantification and count of OSCC could also aid in a quick read-out, and aid
burden of training for volunteers in these high-risk settings. Also, a clear diagnosis based on
optical image features might be a stronger motivator for compliance in going to a clinic,
compared to the previously described study that flagged suspicious lesions, but required the
patient to visit a hospital or clinic for biopsy and diagnosis. Advances in telemedicine also mean
that future image acquisition could be reviewed and approved without requiring a secondary
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visit, which could reduce the necessary workload for volunteers and reduce time between cancer
detection and treatment.
2. Image feature quantification and alternative contrast agent for a translational
microendoscopy system
Recurrence rates in colorectal cancer (CRC) are significant; 44% of stage II and III cases
in one randomized study required additional surgery due to recurrence [17]. Due to the high risk
of recurrence, patients who have undergone CRC-related surgery are placed under increased
surveillance for early detection of additional tumors. Optical imaging devices that have studied
early morphological changes include chromoendoscopy, narrow band imaging, and
microendoscopic systems [18-23]. Fluorescence microendoscopic systems, similar to the one
used in our studies, have shown over 90% sensitivity and specificity with trained observers
classifying images acquired with a proflavine hemisulfate solution [24]. Automated
quantification of images acquired with fluorescence microendoscopy could provide the clinician
with additional parameters to make an informed decision. We designed a custom algorithm for
crypt detection and image segmentation, and tested it using both proflavine and fluorescein –
presented as an alternative contrast agent for microendoscopic systems [25, 26].
Morphological structures that are quantifiable using a fluorescent dye include crypt size
and area. Our custom algorithm had an 85% crypt detection sensitivity with proflavine, and over
90% with fluorescein, and showed decreased area in crypt circularity for crypts in regions of
adenocarcinoma [26]. While microendoscopic imaging studies have shown promise in
qualitative image analysis of colorectal epithelium, quantitative analysis of crypt structure as
biomarkers of carcinoma had not been explored for this type of system.
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As mentioned previously, optical imaging compromises field-of-view for resolution;
microendoscopic images can display clear crypt structures, but the field-of-view is
approximately 1mm in diameter. In addition, microendoscopy can only image the surface of the
epithelial layer, therefore any changes that occur in the base of the crypts are not acquired by the
system. Future work will lie in the direction of an imaging system that combines imaging and
another acquisition technique, such as the diffuse reflectance spectroscopy system in
development by Greening et. al. that combines microendoscopy with diffuse reflectance for
acquisition of hemoglobin and oxygenation biomarkers that are below the imaged surface [27].
The results of our custom algorithm using both proflavine and fluorescein could guide the
implementation of automated image analysis quantification in microendoscopic imaging studies,
such as the measurement of crypt area and circularity, which showed promise for differentiating
normal and carcinoma epithelial regions. Additional parameters that could be tested using
automated quantification include crypt count and distribution, and crypt homogeneity by
measuring the variance/standard deviation of crypt area, and circularity in a field-of-view, as we
applied in our manuscript on SHG imaging [28]. In addition, the use of topical fluorescein
should be tested in vivo for rapid staining of colorectal tissue, similar to studies that have used
intravenous fluorescein to image colorectal epithelium in CRC patients [29, 30].
Efficient image analysis software could be studied for future translation into in vivo
clinical studies. Rapid quantification could provide clinicians with in vivo results for a less
subjective determination of changes in crypt structure. Also, topical application of fluorescein
could prove to be a more translatable fluorescent option for microendoscopic imaging systems
designed for clinical use in complement to current imaging tools, since it is an FDA-approved
contrast agent for intravenous use in ophthalmological imaging applications. A rapid imaging
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system for screening of high-risk patients could aid in early detection of recurrent tumors and
therefore improve survival rates of CRC patients.
3. Second harmonic generation imaging of murine epithelium for crypt morphology image
feature analysis of spontaneous and colitis-associated colorectal tumors
Patients with ulcerative colitis (UC), a subtype of inflammatory bowel disease, have
chronic inflammation of the gastrointestinal tract and have been considered at increased risk for
CRC. Approximately 29% of UC patients develop CRC within 10 years of diagnosis [31-34].
The curative standard in UC patients are partial or complete colectomies when malignant lesions
develop in the colorectal tract [35, 36]. Studies show that UC patients can develop polyps that
are similar to spontaneous polyps developed in patients with no history of inflammatory disease,
and can be treated less aggressively than colitis-associated lesions [19, 36]. Therefore, there have
been a variety of devices and studies designed to distinguish between an adenoma-like mass
(ALM), which can be treated with a less invasive polypectomy, and dysplasia-associated lesion
or mass (DALM), which necessitates a more invasive surgery [19, 36]. Examples of such
modalities include chromoendoscopy and confocal endomicroscopy systems [19, 30].
Multiphoton imaging systems have additional advantages, including acquisition of functional
data acquired from endogenous autofluorescence (e.g. cellular metabolic biomarkers including
redox ratios) instead of exogenous contrast agents. These advantages have led to the
miniaturization of multiphoton systems, which have been designed to be used endoscopically
[37, 38]. Multiphoton imaging allows for not only fluorescence imaging, which provides
functional data, but second harmonic generation (SHG) imaging, which can provide information
of structural collagen [39]. While collagen structures in various types of cancers, including
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cervical and breast, have been investigated using SHG, there has not been extensive study in
SHG imaging of CRC [37, 38, 40].
One approach to imaging of spontaneous and colitis-associated lesions is second
harmonic imaging (SHG) for analysis of collagen structures in colorectal epithelium. We used
A/J mice in two murine tumor models, azoxymethane (AOM) and azoxymethane followed by
rounds of dextran sodium sulfate salt (AOM-DSS), in order to acquire preliminary results of the
viability of using SHG for analysis of changes in crypt structure. We also acquired images from
early and late time points (20-24 weeks and 24-28 weeks post-first-AOM injection, respectively).
Our results showed that the nearest neighbor image feature, the distance between each crypt
center and its nearest crypt center, was the most promising quantitative metric for distinguishing
between cohorts [26]. The average nearest neighbor distances were greater for the AOM late
cohort when compared to AOM-DSS early and late cohorts, while the standard deviation of
nearest neighbor distances showed an increased heterogeneity in AOM late cohort when
compared to AOM-DSS late and Control cohorts. Quantitative analysis of crypt features,
specifically nearest neighbor, showed the potential for SHG imaging to be used as a
complementary tool in distinguishing between ALM and DALM regions.
A disadvantage of using SHG is that the signal is predominantly forward-scattering,
therefore the backscattered signal is dim. The multiphoton imaging system is very sensitive to
movement and can take up to three seconds to acquire an image, which, combined with a small
field-of-view (522x522 μm), makes it difficult to rapidly scan large sections of the colon.
Alternative approaches to scanning of two-photon excitation, such as temporally focused twophoton endomicroscopy, have been studied in order to reduce acquisition time, but they have
their own limitations that must be validated and implemented, such as development of custom
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fibers (e.g. hollow core photonic crystal) that can withstand increased power without damage
[41]. If alternatives that reduce acquisition time can be implemented in miniaturized multiphoton
systems, multiphoton imaging would be effective when used as an optical biopsy to further
inspect grossly suspicious regions during surveillance.
SHG and quantitative analysis of image features, such as nearest neighbor, could serve as
a complementary dataset in studies using miniaturized multiphoton systems. The results of our
quantification could guide future multiphoton studies of ALM and DALM murine models, such
as in vivo studies to determine efficacy of combining autofluorescence and SHG acquisition for
differentiation of lesions, as well as to more thoroughly understand the morphological changes
that occur in crypts in ALM versus DALM tumors.
Combined with additional image features, SHG imaging could eventually aid clinicians
in determining lesion type and optimal treatment in UC patients. Automated quantification of
SHG image features could potentially contribute toward better-informed clinical decisions during
screening and diagnosis of suspicious lesions and polyps during surveillance. Accurate and rapid
assessment of lesions would decrease time in surgery, the need for additional surgeries, and
prevent unnecessary colectomies.
4. Concluding remarks
Optical imaging modalities designed for imaging of epithelial cancer, specifically oral and
colorectal, have been widely studied due to their wide range of applications. Contrast agents are
a crucial component of optical imaging design, whether exogenous or endogenous. We analyzed
the morphology of oral and colorectal epithelium in order to test alternative contrast agents and
the viability of computer-aided quantification in various optical imaging modalities aimed at
cancer detection. Cancer diagnosis, surveillance, and treatment can benefit from systems
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designed to reduce invasiveness, turn-around time, and interobserver variability, as well as
increase detection at early stages and therefore increase survival rates.
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Supplementary Information for Chapter 5 [1]
S1. Optimization of automated crypt detection sensitivity
In previous work, we developed an algorithm for determining optimal contrast-enhancing
parameters for binarizing grayscale images of colon epithelium [2, 3]. The acquired second
harmonic generation (SHG) images were re-scaled between 0 and 1, and the thresholds for
binarizing were optimized for maximizing the ability of the algorithm to segment crypts, which
can vary depending on the strength of the SHG signal in the tissue. Figure S1 shows an example
of how different thresholds are optimal for different images. A range of thresholds were applied
to the images, and the percent crypt detection sensitivity (% CDS) of each group was calculated
against the manual selection of crypts by the authors, as done in previous work [2]. An example
of the % CDS of various thresholds on SHG images of murine colonic tissue from
azoxymethane-injected mice is shown in Fig. S1(e). The thresholds were values between 0 and 1,
used to determine binarization based on all intensities greater than the threshold being converted
to white and all intensities less than the threshold being converted to black. The thresholds we
tested are smaller than 0.01 since the raw image intensities are low for back-scattered SHG
signal. The threshold with highest overall % CDS was 0.0035 with 38% CDS.
Figure S1, specifically (a-d), also shows an example of how different thresholds are
optimal for different images, thus affecting % CDS when a single threshold is chosen. Previous
work showed that applying a range of thresholds to the images increased the % CDS of the
algorithm [2, 3]. The detected crypts for each threshold were compared to the detected crypts of
the previous threshold, and duplicates were excluded while newly-detected crypts were stored. In
order to determine the optimal combination of thresholds, the algorithm applied various
combinations of thresholds to the image set and calculated the % CDS of each combination.
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Since thresholds between 0.003 and 0.005 showed % CDS higher than 20%, the range of tested
combinations included thresholds between 0.0025 and 0.0055, in 0.0005 incremental steps.
Thresholds were tested in combination of two, three, four, and five thresholds. The optimal
combination of thresholds was determined to be a combination of three thresholds: 0.003,
0.0035, and 0.0045 was calculated to have a 67% CDS. Combinations of four or more thresholds
increased % CDS to almost 69%, but also carry the potential for overtraining the algorithm with
our data set, therefore the combination of three thresholds was selected. The selected optimal
parameters for the SHG image data set was calculated to have a 67% crypt detection sensitivity
(CDS), when compared to manual selection of crypt locations.

Figure S1. (a-d) Example of two images from Control mice, binarized using different thresholds.
Yellow is SHG signal, blue is background. Red arrows point to crypts with uncertain definition
at a given threshold; black arrows point to matching crypts that have clear definition at a
different threshold. (e) Plot of percent crypt detection sensitivity (% CDS) of the algorithm at
different threshold values.

S2. Selection of quantifiable image features
Crypt and cellular morphology are image features used by pathologists when determining
a diagnosis for both spontaneous and colitis-associated tumors. Image features include enlarged
or non-tubular crypt shapes, and/or crypts with more than a single layer of cells surrounding it.
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Based on the crypt morphology changes that occur during tumor development, we tested various
image morphology parameters for viability as indicators of colon cancer, specifically crypt
shape, size, and distribution. We tested various image features in order to provide additional
information for investigations using multiphoton endoscopic systems, but we acknowledge that
there are limitations to SHG imaging and crypt morphology when analyzed independent of
additional factors. For example, Figure S2 shows SHG images of Control tissue, as well as of
AOM-DSS early and AOM-DSS late cohorts. Our crypt detection algorithm is designed to detect
and analyze crypts, but tumors, such as the ones labelled with yellow arrows, are not recognized
during automated analysis. There is still the need for the judgement of a clinician/investigator
during the imaging process.
We describe SHG as a complementary optical imaging process to autofluorescence
multiphoton imaging. There have been a number of studies on cancer imaging using
autofluorescence imaging using endoscopic multiphoton systems [4]. An example of the
combined effect of SHG and autofluorescence imaging of a Control tissue sample is shown in
Figure S2. Autofluorescence imaging can acquire cellular and subcellular detail, while SHG
imaging acquires detail of collagen structures. Autofluorescence in Fig. S2 was acquired using a
multiphoton microscopy system (described on page 7 of the main manuscript) which uses a
titanium-sapphire ultrafast femtosecond pulsed laser source (Mai Tai eHP, Spectra-Physics, CA,
USA) which was set to 750nm excitation, and the signal was collected using a 466/40 bandpass
filter (Semrock, NY, USA) and photomultiplier tube (H7422 PASO, Hamamatsu, Japan). We
believe that the combination of SHG and autofluorescence imaging in endoscopic multiphoton
studies of colorectal cancer could elucidate additional morphological changes and markers of
neoplasia and cancer.
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Figure S2. Example SHG images of Control, AOM-DSS early, and AOM-DSS late tissue;
yellow arrows point to tumor edge. Also, example of the combination of SHG and
autofluorescence imaging, using Control epithelium. Scale bar is 100 μm.

166

S3. Image segmentation and quantification of crypt structures
After the selection of the optimal thresholds, the images were binarized, and the objects
in the binary image were then eroded and dilated (5 pixel diameter disk) to discard objects too
small to be crypts as well as reduce rough edges stemming from image noise.
The segmented objects, or detected crypt structures, were then analyzed for quantification
of the following image features: crypt area, circularity, eccentricity, perimeter, distance to the
nearest neighbor (distance from each centroid to the closest centroid), and average of a centroid
distance function (distance from the centroid to each boundary pixel). Previous work details
specifics of automated crypt area and circularity quantification [2, 3]. For automated crypt area,
circularity, and perimeter quantification (Fig. S3), the automated quantification of area (A) and
perimeter (P), and therefore by default circularity variables, were converted into microns.

Figure S3. Summary of quantitative image features. Each image feature is described with an
equation and a visual representation of the calculation using an SHG image of normal
epithelium; scale bar is 100 μm.
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Additional image features included: eccentricity, where a is half the length of the major
axis and b is half the length of the minor axis, and distance to the nearest neighbor, which was
calculated by measuring the Euclidean distance between the centroid of a crypt to the centroid of
every other crypt in the image, and selecting the minima, where the (xc, yc) are the coordinates of
the centroid and (xa, yaa) represents the coordinates of all other centroids (Fig. S4). The average
centroid distance function was calculated by measuring the Euclidean distance between the
centroid of a crypt to each of the boundary pixels, and taking an average of the distances per
crypt, where (xc, yc) are the coordinates of the centroid and (xb, yb) are the coordinates of a
boundary pixel, and n is the number of boundary pixels in the object (Fig. S4).
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Figure S4. Summary of quantitative image features. Each image feature is described with an
equation and a visual representation of the calculation using an SHG image of normal
epithelium; scale bar is 100 μm.
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S4. Additional results of image segmentation and quantification of crypt structures
A full set of the results of the one-way ANOVA comparison, including those not shown
in the manuscript and those which are not statistically significant, are shown below. In general,
for both individual images acquired at a fixed depth (20 μm) and image depth stacks, the mean
and standard deviation of each image feature (Fig. S3 and S4) within each image were quantified
using an adaptation of a previously developed algorithm [2, 3]. The standard deviation of the
image features within each image was calculated in order to measure the heterogeneity of the
crypt structures; for example, tumor-adjacent regions tend to have both abnormally large and
abnormally small crypt structures. A global average across these values would yield a mean
value similar to that derived from normal tissue, but the standard deviation of crypt areas within
an image would report this variance in a more representative manner.
The results of image feature quantification were then compared across cohorts: AOM
early time point, AOM late time point, AOM-DSS early time point, AOM-DSS late time point,
and Control. Nested one-way ANOVA with Tukey’s post-test was used to determine statistically
significant differences between the cohorts (JMP Pro 13). For all images, total image acquisition
time was approximately 1.5 seconds, with total optical power at the sample limited to prevent
photo-damage. Individual images were acquired at 512 x 512 pixels at 14-bit depth, yielding a
522 μm x 522 μm (~0.27 mm2) field of view, at approximately 20 μm from the epithelial
surface. Image depth stacks were acquired at consecutive depths from the epithelial surface, in
20 μm steps, from 20 μm to 100 μm below the epithelial surface.
S5. Fixed image depth results (20 μm)
The comparison of the means (Fig. S5) and standard deviations (Fig. S6) for each of the
image features discussed previously (Fig. S3 and S4) are shown: crypt area, nearest neighbor,
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circularity, perimeter, crypt count, eccentricity, average centroid distance function, minimum
centroid distance function, and maximum centroid distance function. For mean (Fig. S5), the two
image features with statistical significance between cohorts were nearest neighbor and crypt
count. For standard deviation (Fig. S6), the image features with statistical significance were
nearest neighbor, circularity, and eccentricity. They all showed a difference between the Control
cohort and one or more of the tumor-bearing cohorts, but this is not outside of what has been
shown with confocal laser microendoscopy systems such as the Cellvizio® (which differentiated
between colorectal lesions and adjacent normal colorectal epithelial crypt structure in a
preliminary clinical trial) [5].
The differences of interest are in the distinction in mean (Fig. S5) of nearest neighbor
between the AOM late and AOM-DSS early cohorts, as well as the AOM late and the AOMDSS late cohorts. For standard deviation (Fig. S6), the difference of interest is also for nearest
neighbor, between AOM late and AOM-DSS late cohorts. These results suggest that
morphological biomarkers in SHG images of colorectal epithelium could be used to distinguish
between spontaneous tumor development (AOM model) and colitis-associated tumor
development (AOM-DSS model). While the alternative image features did not show statistical
significance in our study, this does not conclusively rule them out as incapable of providing
additional information about the morphological differences between cohorts. Further study into
these or similar features could prove useful in development of clinical imaging systems and
guides for interpreting the acquired images.
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Figure S5. Mean values of various image features: crypt count, crypt area, crypt circularity,
crypt eccentricity, nearest neighbor, average centroid distance function (CDF). Cohort n values
(images): AOM early n=48, AOM late n=23, AOM-DSS early n=45, AOM-DSS late n=24,
Control n=55. Error bars are standard error; significance was calculated via a nested one-way
ANOVA with Tukey’s HSD post-test. Significance was noted (*) for p values <0.05 and (**) for
p values <0.01.
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Figure S6. Standard deviation values of various image features: crypt count, crypt area, crypt
circularity, crypt eccentricity, nearest neighbor, average centroid distance function (CDF).
Cohort n values (images): AOM early n=48, AOM late n=23, AOM-DSS early n=45, AOM-DSS
late n=24, Control n=55. CDF = centroid distance function. Error bars are standard error;
significance was calculated via a nested one-way ANOVA with Tukey’s HSD post-test.
Significance was noted (*) for p values <0.05 and (**) for p values <0.01
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S6. Image depth stack results
The comparison of the means and standard deviations for each of the image features
discussed previously (Fig. S3 and S4) were calculated across a fixed depth (20 to 100 μm) and
compared across cohorts. The image stacks were also compared within cohorts (fixed groups)
across varying acquisition depth for the means and standard deviation of each of the image
features. Due to the extensive number of comparisons, as well as due to the majority not showing
statistical significance, only the image features with at least one statistically significant
difference between two cohorts are shown below. For comparison of means across cohorts (Fig.
S7), the image feature with statistical significance between cohorts was nearest neighbor at 40
μm. To compare standard deviation values across cohorts (Fig. S8), the image features with
statistical significance were area, perimeter, and nearest neighbor at 40 μm, and circularity at 60
μm. To compare mean values across acquisition depths there are no figures, as no image feature
showed statistical significance between cohorts. For comparison of standard deviations across
acquisition depths (Fig. S9), the image features with statistical significance were circularity
within the AOM late cohort, and circularity and eccentricity within the Control cohort.
Several of the image features, including nearest neighbor, area, perimeter, circularity, and
eccentricity showed a difference between the Control cohort and one or more of the tumorbearing cohorts. While these results corroborate that there are morphological differences between
regions of dysplasia and healthy epithelium, they do not show clear usefulness in distinguishing
between spontaneous tumor development (AOM model) and colitis-associated tumor
development (AOM-DSS model). Though this does not prove them incapable of providing
additional information about the morphological differences between cohorts, further study into
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depth section and/or volumetric analysis of crypt morphology is needed to better understand any
differences between spontaneous and colitis-associated tumor development.

Figure S7. Mean values of crypt nearest neighbor at 40 μm of acquisition depth across cohorts.
Cohort n values (stacks): AOM early n=8, AOM late n=9, AOM-DSS early n=5, AOM-DSS late
n=12, Control n=9. Significance was calculated via two-way ANOVA with Tukey’s post-test.
Error bars are standard error Significance was noted (*) for p values <0.05 and (**) for p values
<0.01.
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Figure S8. Standard deviation values of area, perimeter, and nearest neighbor at 40 μm of
acquisition depth across cohorts, and of circularity at 60 μm of acquisition depth across cohorts.
Cohort n values (stacks): AOM early n=8, AOM late n=9, AOM-DSS early n=5, AOM-DSS late
n=12, Control n=9. Significance was calculated via two-way ANOVA with Tukey’s post-test.
Error bars are standard error Significance was noted (*) for p values <0.05 and (**) for p values
<0.01.
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Figure S9. Standard deviation values of crypt circularity of AOM late cohort across acquisition
depths, and of crypt circularity and eccentricity of Control cohort across acquisition depth.
Cohort n values (stacks): AOM late n=9, Control n=9. Significance was calculated via two-way
ANOVA with Tukey’s post-test. Error bars are standard error Significance was noted (*) for p
values <0.05 and (**) for p values <0.01.
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